Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q


☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2023


☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 001-34362

Columbus McKinnon Corporation

(Exact name of registrant as specified in its charter)

New York

16-0547600

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

13320 Ballantyne Corporate Place, Suite D

Charlotte

28277

(Address of principal executive offices)

(Zip code)

(716)

689-5400

(Registrant's telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report.)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $0.01 par value per share	CMCO	Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. : ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definition of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer

☒

Accelerated filer

☐

Non-accelerated filer

☐

Smaller reporting company

☐

Emerging growth company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

The number of shares of common stock outstanding as of January 29, 2024 was: 28,755,978 shares.

FORM 10-Q INDEX

COLUMBUS McKINNON CORPORATION

For the quarterly period ended December 31, 2023


		Page #
Part I. Financial Information

Item 1.	Condensed Consolidated Financial Statements (Unaudited).

	Condensed consolidated balance sheets - December 31, 2023 and March 31, 2023	3

	Condensed consolidated statements of operations - Three and nine months ended December 31, 2023 and December 31, 2022	4

	Condensed consolidated statements of comprehensive income (loss) - Three and nine months ended December 31, 2023 and December 31, 2022	5

	Condensed consolidated statements of shareholders' equity - Three and nine months ended December 31, 2023 and December 31, 2022	6

	Condensed consolidated statements of cash flows - Nine months ended December 31, 2023 and December 31, 2022	8

	Notes to condensed consolidated financial statements - December 31, 2023	9

Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations.	30

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	36

Item 4.	Controls and Procedures.	36

Part II. Other Information

Item 1.	Legal Proceedings.	37

Item 1A.	Risk Factors.	37

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	37

Item 3.	Defaults U pon Senior Securities.	37

Item 4.	Mine Safety Disclosures.	37

Item 5.	Other Information.	37

Item 6.	Exhibits.	38

Part I. Financial Information

Item 1. Condensed Consolidated Financial Statements (Unaudited).

COLUMBUS McKINNON CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS


	December 31, 2023		March 31, 2023
	(unaudited)
ASSETS:	(In thousands)
Current assets:
Cash and cash equivalents	$	102,945	$	133,176
Trade accounts receivable, less allowance for doubtful accounts ($3,955 and $3,620, respectively)	173,411		151,451
Inventories	204,396		179,359
Prepaid expenses and other	35,660		32,254
Total current assets	516,412		496,240
Property, plant, and equipment, net	102,729		94,360
Goodwill	728,427		644,629
Other intangibles, net	396,317		362,537
Marketable securities	12,388		10,368
Deferred taxes on income	1,990		2,035
Other assets	99,047		88,286
Total assets	$	1,857,310	$	1,698,455

LIABILITIES AND SHAREHOLDERS' EQUITY:
Current liabilities:
Trade accounts payable	$	76,151	$	76,736
Accrued liabilities	142,518		124,317
Current portion of long-term debt and finance lease obligations	50,652		40,604
Total current liabilities	269,321		241,657
Term loan, AR securitization facility and finance lease obligations	499,388		430,988
Other non current liabilities	210,164		192,013
Total liabilities	978,873		864,658
Shareholders' equity:
Voting common stock; 50,000,000 shares authorized; 28,755,651 and 28,611,721 shares issued and outstanding	288		286
Treasury stock	(1,001)		(1,001)
Additional paid in capital	522,587		515,797
Retained earnings	387,550		356,758
Accumulated other comprehensive loss	(30,987)		(38,043)
Total shareholders' equity	878,437		833,797
Total liabilities and shareholders' equity	$	1,857,310	$	1,698,455

See accompanying notes.

COLUMBUS McKINNON CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)


	Three Months Ended				Nine Months Ended
	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
	(In thousands, except per share data)
Net sales	254,143		230,370		748,036		682,397
Cost of products sold	160,246		148,326		467,513		431,516
Gross profit	93,897		82,044		280,523		250,881

Selling expenses	26,552		25,424		78,400		77,197
General and administrative expenses	26,255		25,143		79,407		68,441
Research and development expenses	6,692		4,839		19,134		15,429
Amortization of intangibles	7,486		6,459		21,871		19,442
	66,985		61,865		198,812		180,509

Income from operations	26,912		20,179		81,711		70,372
Interest and debt expense	9,952		7,303		28,788		20,274

Investment (income) loss	(758)		(574)		(1,212)		168
Foreign currency exchange (gain) loss	(1,155)		(3,359)		1,074		(1,152)
Other (income) expense, net	5,234		79		5,840		(1,999)
Income (loss) before income tax expense (benefit)	13,639		16,730		47,221		53,081
Income tax expense (benefit)	3,911		4,701		12,405		18,547
Net income (loss)	$	9,728	$	12,029	$	34,816	$	34,534

Average basic shares outstanding	28,744		28,626		28,711		28,597
Average diluted shares outstanding	28,991		28,778		28,979		28,767

Basic income (loss) per share:	$	0.34	$	0.42	$	1.21	$	1.21

Diluted income (loss) per share:	$	0.34	$	0.42	$	1.20	$	1.20

Dividends declared per common share	$	0.07	$	0.07	$	0.14	$	0.14

See accompanying notes.

COLUMBUS McKINNON CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(UNAUDITED)


	Three Months Ended				Nine Months Ended
	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
	(In thousands)				(In thousands)
Net income (loss)	$	9,728	$	12,029	$	34,816	34,534
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	13,339		12,272		6,557		(7,210)
Change in derivatives qualifying as hedges, net of taxes of $1,350, $(595), $1,260 ,$(2,833)	(4,206)		1,962		(3,930)		9,337
Change in pension liability and postretirement obligation, net of taxes of $(1,511), $73, $(1,489), $(26)	4,595		(230)		4,429		82
Total other comprehensive income (loss)	13,728		14,004		7,056		2,209
Comprehensive income (loss)	$	23,456	$	26,033	$	41,872	$	36,743

See accompanying notes.

COLUMBUS McKINNON CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(UNAUDITED)


	(In thousands, except share data)
	Common Stock ($0.01 par value)		Treasury Stock		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders’ Equity
Balance at March 31, 2023	$	286	$	(1,001)	$	515,797	$	356,758	$	(38,043)	$	833,797
Net income (loss)	—		—		—		9,275		—		9,275
Change in foreign currency translation adjustment	—		—		—		—		2,901		2,901
Change in derivatives qualifying as hedges, net of tax of $(176)	—		—		—		—		541		541
Change in pension liability and postretirement obligations, net of tax of $(5)	—		—		—		—		42		42
Stock options exercised,8,485 shares	—		—		225		—		—		225
Stock compensation expense	—		—		1,981		—		—		1,981
Restricted stock units released, 87,496 shares, net of shares withheld for minimum statutory tax obligation	1		—		(1,806)		—		—		(1,805)
Balance at June 30, 2023	$	287	$	(1,001)	$	516,197	$	366,033	$	(34,559)	$	846,957
Net income (loss)	—		—		—		15,813		—		15,813
Dividends declared	—		—		—		(2,012)		—		(2,012)
Change in foreign currency translation adjustment	—		—		—		—		(9,683)		(9,683)
Change in derivatives qualifying as hedges, net of tax of $86	—		—		—		—		(265)		(265)
Change in pension liability and postretirement obligations, net of tax of $27	—		—		—		—		(208)		(208)
Stock compensation - directors	—		—		587		—		—		587
Stock options exercised, 9,556 shares	—		—		265		—		—		265
Stock compensation expense	—		—		2,696		—		—		2,696
Restricted stock units released, 19,653 shares, net of shares withheld for minimum statutory tax obligation	—		—		(152)		—		—		(152)
Balance at September 30, 2023	$	287	$	(1,001)	$	519,593	$	379,834	$	(44,715)	$	853,998
Net income	—		—		—		9,728		—		9,728
Dividends declared	—		—		—		(2,012)		—		(2,012)
Change in foreign currency translation adjustment	—		—		—		—		13,339		13,339
Change in derivatives qualifying as hedges, net of tax of $1,350	—		—		—		—		(4,206)		(4,206)
Change in pension liability and postretirement obligations, net of tax of $(1,511)	—		—		—		—		4,595		4,595
Stock compensation - directors	—		—		293		—		—		293
Stock options exercised, 2,900 shares	—		—		66		—		—		66
Stock compensation expense	—		—		2,916		—		—		2,916

Restricted stock units released, 15,840 shares, net of shares withheld for minimum statutory tax obligation	1		—		(281)		—		—		(280)
Balance at December 31, 2023	$	288	$	(1,001)	$	522,587	$	387,550	$	(30,987)	$	878,437

See accompanying notes.

COLUMBUS McKINNON CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

(UNAUDITED)


	(In thousands, except share data)
	Common Stock ($0.01 par value)		Treasury Stock		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Loss		Total Shareholders’ Equity
Balance at March 31, 2022	$	285	$	—	$	506,074	$	316,343	$	(49,899)	$	772,803
Net income (loss)	—		—		—		8,391		—		8,391
Change in foreign currency translation adjustment	—		—		—		—		(8,701)		(8,701)
Change in derivatives qualifying as hedges, net of tax of $(812)	—		—		—		—		2,689		2,689
Change in pension liability and postretirement obligations, net of tax of $(49)	—		—		—		—		146		146
Stock options exercised, 18,907 shares	—		—		415		—		—		415
Stock compensation expense	—		—		751		—		—		751
Restricted stock units released, 52,276 shares, net of shares withheld for minimum statutory tax obligation	1		—		(1,314)		—		—		(1,313)
Balance at June 30, 2022	$	286	$	—	$	505,926	$	324,734	$	(55,765)	$	775,181
Net income (loss)	—		—		—		14,114		—		14,114
Dividends declared	—		—		—		(2,004)		—		(2,004)
Change in foreign currency translation adjustment	—		—		—		—		(10,781)		(10,781)
Change in derivatives qualifying as hedges, net of tax of $(1,509)	—		—		—		—		4,686		4,686
Change in pension liability and postretirement obligations, net of tax of $(56)	—		—		—		—		166		166
Stock compensation - directors	—		—		537		—		—		537
Stock options exercised, 9,531 shares	—		—		206		—		—		206
Stock compensation expense	—		—		2,341		—		—		2,341
Restricted stock units released, 31,313 shares, net of shares withheld for minimum statutory tax obligation	—		—		(62)		—		—		(62)
Balance at September 30, 2022	$	286	$	—	$	508,948	$	336,844	$	(61,694)	$	784,384
Net income (loss)	—		—		—		12,029		—		12,029
Dividends declared	—		—		—		(2,005)		—		(2,005)
Change in foreign currency translation adjustment	—		—		—		—		12,272		12,272
Change in derivatives qualifying as hedges, net of tax of $(595)	—		—		—		—		1,962		1,962
Change in pension liability and postretirement obligations, net of tax of $73	—		—		—		—		(230)		(230)
Stock compensation - directors	—		—		316		—		—		316
Stock options exercised, 3,258 shares	—		—		83		—		—		83
Stock compensation expense	—		—		3,094		—		—		3,094
Treasury Stock Purchase, 31,085 shares	—		(1001)		—		—		—		(1,001)
Restricted stock units released, 6,798 shares, net of shares withheld for minimum statutory tax obligation	—		—		(23)		—		—		(23)
Balance at December 31, 2022	$	286	$	(1,001)	$	512,418	$	346,868	$	(47,690)	$	810,881

See accompanying notes.

COLUMBUS McKINNON CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)


	Nine Months Ended
	December 31, 2023		December 31, 2022
OPERATING ACTIVITIES:	(In thousands)
Net income (loss)	34,816		34,534
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation and amortization	34,052		31,380
Deferred income taxes and related valuation allowance	(6,495)		(783)
Net loss (gain) on sale of real estate, investments and other	(967)		347
Non-cash pension settlement (See Note 10)	4,599		—
Stock-based compensation	8,473		7,039
Amortization of deferred financing costs	1,728		1,291

Loss (gain) on hedging instruments	1,193		(598)
Gain on sale of building	—		(232)
Loss on retirement of fixed asset	—		175
Non-cash lease expense	7,080		5,814
Changes in operating assets and liabilities, net of effects of business acquisitions:
Trade accounts receivable	(14,911)		(1,401)
Inventories	(17,764)		(31,701)
Prepaid expenses and other	(2,897)		4,905
Other assets	(859)		(232)
Trade accounts payable	(1,387)		(18,756)
Accrued liabilities	(7,236)		(7,498)
Non-current liabilities	(10,834)		(7,382)
Net cash provided by (used for) operating activities	28,591		16,902

INVESTING ACTIVITIES:
Proceeds from sales of marketable securities	1,101		2,650
Purchases of marketable securities	(2,731)		(3,121)
Capital expenditures	(16,334)		(9,511)
Proceeds from sale of building, net of transaction costs	—		373
Dividend received from equity method investment	144		313

Purchase of businesses, net of cash acquired (See Note 2)	(108,145)		(1,616)
Net cash provided by (used for) investing activities	(125,965)		(10,912)

FINANCING ACTIVITIES:
Proceeds from the issuance of common stock	556		704
Purchases of treasury stock	—		(1,001)
Repayment of debt	(40,447)		(30,402)
Proceeds from issuance of long-term debt	120,000		—
Fees paid for borrowings on long-term debt	(2,859)		—

Cash inflows from hedging activities	18,088		18,422
Cash outflows from hedging activities	(19,303)		(17,958)
Payment of dividends	(6,027)		(6,006)
Other	(2,237)		(1,398)
Net cash provided by (used for) financing activities	67,771		(37,639)
Effect of exchange rate changes on cash	(628)		(2,221)
Net change in cash and cash equivalents	(30,231)		(33,870)
Cash, cash equivalents, and restricted cash at beginning of year	133,426		115,640
Cash, cash equivalents, and restricted cash at end of period	$	103,195	$	81,770

Supplementary cash flow data:
Interest paid	$	25,332	$	18,883
Income taxes paid, net of refunds	$	21,561	$	18,486
Property, plant and equipment purchases included in trade accounts payable	$	135	$	199
Restricted cash presented in Other assets	$	250	$	250

See accompanying notes.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

December 31, 2023

1. Description of Business

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the financial position of Columbus McKinnon Corporation ("the Company") at December 31, 2023, the results of its operations for the three and nine months ended December 31, 2023 and December 31, 2022, and cash flows for the nine months ended December 31, 2023 and December 31, 2022, have been included. Results for the period ended December 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2024. The balance sheet at March 31, 2023 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in the Columbus McKinnon Corporation Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “2023 10-K”).

The Company is a leading worldwide designer, manufacturer, and marketer of intelligent motion solutions that efficiently and ergonomically move, lift, position, and secure materials. Key products include hoists, crane components, precision conveyor systems, accumulation tables, rigging tools, light rail workstations, and digital power and motion control systems. The Company is focused on commercial and industrial applications that require the safety and quality provided by its superior design and engineering know-how.

The Company’s products are sold globally, principally to third party distributors and crane builders through diverse distribution channels, and to a lesser extent directly to end-users and integrators. During the nine months ended December 31, 2023, sales to customers in the United States were approximately 56% of total net sales.

2. Acquisitions & Disposals

On May 31, 2023, the Company completed its acquisition of montratec GmbH ("montratec") for $115,721,000 including $7,576,000 in cash acquired, a $540,000 working capital settlement, and a contingent payment that becomes payable if a certain EBITDA level for the twelve-month period December 31, 2023 is achieved as set forth in the purchase agreement for montratec. As of December 31, 2023, the Company has estimated this contingent liability to be $18,355,000, a decrease of $6,738,000 from the June 30, 2023 quarter due to a refinement in the estimates used to value the liability at May 31, 2023. This liability has been established in the opening balance sheet for montratec. The Company initially financed the acquisition by borrowing $117,000,000 on its New Revolving Credit Facility, but later repaid the New Revolving Credit Facility by borrowing an additional $120,000,000. Utilizing the Accordion feature under the Company's existing Term Loan B, the Company borrowed $75,000,000 and another $45,000,000 was borrowed through a new credit agreement secured by its U.S. accounts receivable balances. Refer to Note 9 for additional details on the Company's debt agreements.

montratec is a leading automation solutions company that designs and develops intelligent automation and transport systems for interlinking industrial production and logistics processes. montratec product offerings complement the Company's previous acquisitions of both Dorner Mfg. Corp. ("Dorner") and Garvey Corporation ("Garvey"), and furthers the Company's shift to intelligent motion and serves as a platform to expand capabilities in advanced, higher technology automation solutions. As the Company determined that the acquisition is not material to its existing operations, certain disclosures, including pro forma financial information, have not been included. montratec results have been included in the Company's results of operations from the acquisition date and the Company incurred $113,000 and $3,208,000 of acquisition and deal related costs classified as part of General and administrative expenses in the three and nine months ended December 31, 2023.

The purchase price has been preliminarily allocated to the assets acquired and liabilities assumed as of the date of acquisition. The excess consideration of $78,943,000 has been recorded as goodwill, a decrease of $6,414,000 from the amount preliminarily allocated to goodwill as of June 30, 2023 due to decreases of $6,738,000 for the Contingent liability, $577,000 related to a refinement in the calculation of deferred taxes within Other non current liabilities, and an increase of $108,000 in other assets as a result of refinements in estimates to calculate the right of use lease assets. Offsetting these were increases to goodwill as the result of the working capital settlement of $540,000, $260,000 relating to adjustments to working capital, and $209,000 within Property, plant, and equipment, net related to refined estimates for lease-related assets. The identifiable intangible assets acquired include customer relationships valued at $33,471,000, a tradename valued at $2,915,000, and technology valued at $16,196,000. The weighted average life of the acquired identifiable intangible assets subject to

amortization was estimated at 14 years at the time of acquisition. Of the $78,943,000 goodwill recorded from the acquisition, $7,531,000 is deductible for tax purposes.

The preliminary assignment of purchase consideration to the assets acquired and liabilities assumed is as follows (in thousands):


Cash	$	7,576
Working capital	4,896
Property, plant, and equipment, net	2,157
Intangible assets	52,581
Contingent liability (see above)	(18,355)
Other assets	5,704
Other non current liabilities	(17,781)
Goodwill	78,943
Total	$	115,721

3. Revenue & Receivables

Revenue Recognition:

Performance obligations

The Company has contracts with customers for standard products and custom engineered products and determines when and how to recognize revenue for each performance obligation based on the nature and type of contract.

Revenue from contracts with customers for standard products is recognized when legal title and significant risk and rewards has transferred to the customer, which is generally at the time of shipment. This is the point in time when control is deemed to transfer to the customer. The Company sells standard products to customers utilizing purchase orders. Payment terms for these types of contracts generally require payment within 30 to 60 days. Each standard product is deemed to be a single performance obligation and the amount of revenue recognized is based on the negotiated price. The transaction price for standard products is based on the price reflected in each purchase order. Sales incentives are offered to customers who purchase standard products and include offers such as volume-based discounts, rebates for priority customers, and discounts for early cash payments. These sales incentives are accounted for as variable consideration included in the transaction price. Accordingly, the Company reduces revenue for these incentives in the period which the sale occurs and is based on the most likely amount method for estimating the amount of consideration the Company expects to receive. These sales incentive estimates are updated each reporting period as additional information becomes available.

The Company also sells custom engineered products and services, which are contracts that are typically completed within one quarter but can extend beyond one year in duration. For custom engineered products, the transaction price is based upon the price stated in the contract. Variable consideration has not been identified as a significant component of transaction price for custom engineered products and services. The Company generally recognizes revenue for custom engineered products upon satisfaction of its performance obligation under the contract which typically coincides with project completion which is when the products and services are controlled by the customer. Control is typically achieved at the later of when legal title and significant risk and rewards have transferred to the customer or the customer has accepted the asset. These contracts often require either up front or installment payments. These types of contracts are generally accounted for as one performance obligation as the products and services are not separately identifiable. The promised services (such as inspection, commissioning, and installation) are essential in order for the delivered product to operate as intended on the customer’s site and the services are therefore highly interrelated with product functionality.

For most custom engineered products contracts, the Company determined that while there is no alternative use for the custom engineered products, the Company does not have an enforceable right to payment (which must include a reasonable profit margin) for performance completed to date in order to meet the over time revenue recognition criteria. Therefore, revenue is recognized at a point in time (when the contract is complete). For custom engineered products contracts that contain an enforceable right to payment (including reasonable profit margin) the Company satisfies the performance obligation over time and recognizes revenue based on the extent of progress towards completion of the performance obligation. The cost-to-cost measure of progress is an appropriate measure of progress toward satisfaction of performance obligations as this measure most accurately depicts the progress of work performed and transfer of control to the customers. Under the cost-to-cost measure of

progress, the extent of progress toward completion is measured based on the ratio of costs incurred to date to the total estimated costs at completion of the performance obligation. Revenues are recognized proportionally as costs are incurred.

Sales and other taxes collected with revenue are excluded from revenue. Shipping and handling costs incurred prior to shipment are considered activities required to fulfill the Company’s promise to transfer goods, and do not qualify as a separate performance obligation. Additionally, the Company offers standard warranties which are typically 12 months in duration for standard products and 24 to 36 months for custom engineered products. These types of warranties are included in the purchase price of the product and are deemed to be assurance-type warranties which are not accounted for as a separate performance obligation. Other performance obligations included in a contract (such as drawings, owner’s manuals, and training services) are immaterial in the context of the contract and are not recognized as a separate performance obligation.

For additional information on the Company’s revenue recognition policy refer to the consolidated financial statements included in the 2023 10-K.

Reconciliation of contract balances

The Company records a contract liability when cash is received prior to recording revenue. Some standard contracts require a down payment while most custom engineered contracts require installment payments. Installment payments for the custom engineered contracts typically require a portion due at inception while the remaining payments are due upon completion of certain performance milestones. For both types of contracts, these contract liabilities, referred to as customer advances, are recorded at the time payment is received and are included in Accrued liabilities on the Condensed Consolidated Balance Sheets. When the related performance obligation is satisfied and revenue is recognized, the contract liability is released into income.

The following table illustrates the balance and related activity for customer advances in the nine months ended December 31, 2023 and December 31, 2022 (in thousands):


Customer advances (contract liabilities)	December 31, 2023		December 31, 2022
March 31, beginning balance	$	27,003	$	22,453
Additional customer advances received	69,188		56,902
Revenue recognized from customer advances included in beginning of period	(27,003)		(22,453)
Other revenue recognized from customer advances	(47,055)		(34,302)
Customer advances recorded from acquisitions	3,866		—
Other (1)	284		(418)
December 31, ending balance	$	26,283	$	22,182

(1) Other includes the impact of foreign currency translation

Revenue was recognized prior to the right to invoice the customer which resulted in a contract asset balance in the amount of $1,500,000 and $2,944,000 as of December 31, 2023 and March 31, 2023, respectively. Contract assets are included in Prepaid expenses and other assets on the Condensed Consolidated Balance Sheets.

Remaining Performance Obligations

As of December 31, 2023, the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) was approximately $11,307,000. We expect to recognize approximately 52% of these sales over the next twelve months.

Disaggregated revenue

In accordance with FASB ASC Topic 606, the Company is required to disaggregate revenue into categories that depict how economic factors affect the nature, amount, timing and uncertainty of revenue and cash flows.

The following table illustrates the disaggregation of revenue by product grouping for the three and nine months ended December 31, 2023 and December 31, 2022 (in thousands):


	Three Months Ended				Nine Months Ended
Net Sales by Product Grouping	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
Industrial Products	$	83,033	$	77,423	$	253,925	$	240,366
Crane Solutions	103,775		97,541		303,746		266,959
Engineered Products	22,710		21,535		70,895		61,309
Precision Conveyor Products	44,588		33,837		119,379		113,646
All other	37		34		91		117
Total	$	254,143	$	230,370	$	748,036	$	682,397

Industrial products include: manual chain hoists, electrical chain hoists, rigging/clamps, industrial winches, hooks, shackles, and other forged attachments. Crane solutions products include: wire rope hoists, drives and controls, crane kits and components, and workstations. Engineered products include: linear and mechanical actuators, lifting tables, rail projects, and actuation systems. Precision conveyor products include: low profile, flexible chain, large scale, sanitary and vertical elevation conveyor systems, pallet system conveyors, accumulation systems, asynchronous conveyors as well as other high-precision conveyance systems. The All other product grouping includes miscellaneous revenue.

Practical expedients

Incremental costs to obtain a contract incurred by the Company primarily relate to sales commissions for contracts with a duration of one year or less. Therefore, these costs are expensed as incurred and are recorded in Selling expenses on the Condensed Consolidated Statements of Operations.

Unsatisfied performance obligations for contracts with an expected length of one year or less are not disclosed. Further, revenue from contracts with customers do not include a significant financing component as payment is generally expected within one year from when the performance obligation is controlled by the customer.

Accounts Receivable:

Under Accounting Standard Update ("ASU") 2016-13, the Company is required to remeasure expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable forecasts. In addition to these factors, the Company establishes an allowance for doubtful accounts based upon the credit risk of specific customers, historical trends, and other factors. Accounts receivable are charged against the allowance for doubtful accounts once all collection efforts have been exhausted. Due to the short-term nature of such accounts receivable, the estimated amount of accounts receivable that may not be collected is based on aging of the accounts receivable balances.

The following table illustrates the balance and related activity for the allowance for doubtful accounts that is deducted from accounts receivable to present the net amount expected to be collected in the nine months ended December 31, 2023 and December 31, 2022 (in thousands):


Allowance for doubtful accounts	December 31, 2023		December 31, 2022
March 31, beginning balance	$	3,620	$	5,717
Bad debt expense	2,727		726
Less uncollectible accounts written off, net of recoveries	(2,490)		(996)
Allowance recorded from acquisitions	64		—
Other (1)	34		(134)
December 31, ending balance	$	3,955	$	5,313

(1) Other includes the impact of foreign currency translation

4. Fair Value Measurements

FASB ASC Topic 820 “Fair Value Measurements and Disclosures” establishes the standards for reporting financial assets and liabilities and nonfinancial assets and liabilities that are recognized or disclosed at fair value on a recurring basis (at least annually). Under these standards, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (i.e. the "exit price") in an orderly transaction between market participants at the measurement date.

ASC 820-10-35-37 establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company's assumptions about the valuation techniques that market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is separated into three levels based on the reliability of inputs as follows:

Level 1 - Valuations based on quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these products does not entail a significant degree of judgment.

Level 2 - Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly, involving some degree of judgment.

Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement. The degree of judgment exercised in determining fair value is greatest for instruments categorized in Level 3.

The availability of observable inputs can vary and is affected by a wide variety of factors, including the type of asset/liability, whether the asset/liability is established in the marketplace, and other characteristics particular to the transaction. To the extent that valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety.

Fair value is a market-based measure considered from the perspective of a market participant rather than an entity-specific measure. Therefore, even when market assumptions are not readily available, assumptions are required to reflect those that market participants would use in pricing the asset or liability at the measurement date.

The Company uses quoted market prices when valuing its marketable securities and, consequently, the fair value is based on Level 1 inputs. These marketable securities consist of equity and fixed income securities. The Company primarily uses readily observable market data in conjunction with internally developed discounted cash flow valuation models when valuing its derivative portfolio and, consequently, the fair value of the Company’s derivatives is based on Level 2 inputs. The carrying amount of the Company's pension-related annuity contract is recorded at net asset value of the contract and, consequently, its fair value is based on Level 2 inputs and is included in Other assets on the Condensed Consolidated Balance Sheets. The carrying value of the Company’s Term Loan approximates fair value based on current market interest rates for debt instruments of similar credit standing and, consequently, their fair values are based on Level 2 inputs.

The following table provides information regarding financial assets and liabilities measured or disclosed at fair value (in thousands):


	Fair value measurements at reporting date using
	December 31,		Quoted prices in active markets for identical assets		Significant other observable inputs		Significant unobservable inputs
Description	2023		(Level 1)		(Level 2)		(Level 3)
Assets/(Liabilities) measured at fair value:
Marketable securities	$	12,388	$	12,388	$	—	$	—
Annuity contract	1,409		—		1,409		—

Derivative Assets (Liabilities):
Foreign exchange contracts	(100)		—		(100)		—
Interest rate swap	6,198		—		6,198		—
Cross currency swap	(4,506)		—		(4,506)		—


Disclosed at fair value:
Term Loan B	$	(500,048)	$	—	$	(500,048)	$	—
AR securitization facility	$	(45,000)	$	—	$	(45,000)	$	—


	Fair value measurements at reporting date using
	March 31,		Quoted prices in active markets for identical assets		Significant other observable inputs		Significant unobservable inputs
Description	2023		(Level 1)		(Level 2)		(Level 3)
Assets/(Liabilities) measured at fair value:
Marketable securities	$	10,368	$	10,368	$	—	$	—
Annuity contract	1,612		—		1,612		—
Derivative assets (liabilities):
Foreign exchange contracts	97		—		97		—

Interest rate swap	10,475		—		10,475		—
Cross currency swap	(2,102)		—		(2,102)		—

Disclosed at fair value:
Term loan B	$	(460,825)	$	—	$	(460,825)	$	—

The Company does not have any non-financial assets and liabilities that are recognized at fair value on a recurring basis. At December 31, 2023, the Term Loan B has been recorded at carrying value, which approximates fair value. In fiscal 2024, the Company also borrowed an additional $45,000,000 under a new credit agreement secured by the Company's U.S. accounts receivable balances (the "AR Securitization Facility"). The AR Securitization Facility has been recorded at carrying value which approximates fair value. Refer to Note 9 for additional information regarding the Company's long-term debt.

Market gains, interest, and dividend income on marketable securities are recorded in Investment (income) loss on the Condensed Consolidated Statements of Operations. Changes in the fair value of derivatives are recorded in foreign currency exchange (gain) loss or other comprehensive income (loss), to the extent that the derivative qualifies as a hedge under the provisions of FASB ASC Topic 815. Interest and dividend income on marketable securities are measured based upon amounts earned on their respective declaration dates.

Assets and liabilities preliminarily recorded at fair value on a non-recurring basis during the nine months ended December 31, 2023 include assets and liabilities acquired in connection with the acquisition of montratec described in Note 2. The estimated fair values allocated to the assets acquired and liabilities assumed relied upon fair value measurements based primarily on Level 3 inputs. The valuation techniques used to allocate fair values to working capital items; property, plant, and equipment, and

identifiable intangible assets included the cost approach, market approach, and other income approaches. For identifiable intangible assets these techniques included the multi-period excess earnings approach, the relief from royalty approach, and other income approaches. The closed-form option price approach was used to calculate the contingent consideration. The valuation techniques relied on a number of inputs which included the cost and condition of property, plant, and equipment and forecasted net sales and income.

Significant valuation inputs included an attrition rate of 10.0% for customer relationships, an estimated royalty rate of 5.0% for technology, a royalty rate of 1.0% for trademark and trade names, an asset volatility rate of 27% for the contingent consideration, and a weighted average cost of capital of 12.5%.

Refer to the 2023 10-K for a full description of the assets and liabilities measured on a non-recurring basis that are included in the Company's March 31, 2023 balance sheet.

5. Inventories

Inventories consisted of the following (in thousands):


	December 31, 2023		March 31, 2023
At cost - FIFO basis:
Raw materials	$	167,833	$	142,490
Work-in-process	26,788		26,323
Finished goods	41,449		39,714
Total at cost FIFO basis	236,070		208,527
LIFO cost less than FIFO cost	(31,674)		(29,168)
Net inventories	$	204,396	$	179,359

The acquisition of montratec contributed $4,083,000 to the increase in inventory since March 31, 2023.

An actual valuation of inventory under the LIFO method can be made only at the end of each year based on the inventory levels and costs at that time. Accordingly, interim LIFO calculations must necessarily be based on management's estimates of expected year-end inventory levels and costs. Because these are subject to many factors beyond management's control, estimated interim results are subject to change in the final year-end LIFO inventory valuation.

6. Marketable Securities and Other Investments

In accordance with ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities,” all equity investments in unconsolidated entities (other than those accounted for using the equity method of accounting) are measured at fair value through earnings. The Company's marketable securities are recorded at their fair value, with unrealized changes in market value realized within Investment (income) loss on the Condensed Consolidated Statements of Operations. The impact on earnings for unrealized gains and losses were gains of $660,000 and $362,000 in the three months ended December 31, 2023 and December 31, 2022, respectively and a gain of $390,000 and a loss of $558,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively.

Consistent with prior periods, the estimated fair value is based on quoted market prices at the balance sheet dates. The cost of securities sold is based on the specific identification method. Interest and dividend income are included in Investment (income) loss in the Condensed Consolidated Statements of Operations.

Marketable securities are carried as long-term assets since they are held for the settlement of the Company’s general and product liability insurance claims filed through CM Insurance Company, Inc. ("CMIC"), a wholly owned captive insurance subsidiary. The marketable securities are not available for general working capital purposes.

Net realized gains related to sales of marketable securities were not material in the three and nine months ended December 31, 2023 and December 31, 2022, respectively.

The Company owns a 49% ownership interest in Eastern Morris Cranes Company Limited ("EMC"), a limited liability company organized and existing under the laws and regulations of the Kingdom of Saudi Arabia. The Company's ownership represents an equity investment in a strategic customer of STAHL serving the Kingdom of Saudi Arabia. The investment's

carrying value is presented in Other assets in the Condensed Consolidated Balance Sheets in the amount of $3,132,000 and $2,752,000 as of December 31, 2023 and March 31, 2023, respectively, and has been accounted for as an equity method investment. The investment value increased for the Company's ownership percentage of income earned by EMC in the amount of $5,000 and $142,000 in the three months ended December 31, 2023 and December 31, 2022, respectively, and increased by $589,000 and $209,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively, recorded in Investment (income) loss on the Condensed Consolidated Statements of Operations. Further, in the nine months ended December 31, 2023 and December 31, 2022, EMC distributed cash dividends which the Company received 49% of pursuant to its ownership interest. The investment value was decreased for the Company's share of EMC's cash dividend in the amount of $247,000 and $313,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively, as they were determined to be a return of the Company's investment. Dividends are included in investing activities on the Condensed Consolidated Statements of Cash Flows in the amount of $144,000 and $313,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively, as the distribution received exceeded cumulative equity in earnings, under the cumulative earnings approach. The remaining balance of the dividend for the nine months ended December 31, 2023, is included in cash flows from operations. The December 31, 2023 and March 31, 2023 trade accounts receivable balance due from EMC are $8,105,000 and $5,083,000, respectively, and are comprised of amounts due for the sale of goods and services in the ordinary course of business.

7. Goodwill and Intangible Assets

Goodwill and indefinite lived trademarks are not amortized but are tested for impairment at least annually, in accordance with the provisions of ASC Topic 350-20-35-1. Goodwill impairment is deemed to exist if the net book value of a reporting unit exceeds its estimated fair value. The fair value of a reporting unit is determined using a discounted cash flow methodology. The Company’s reporting units are determined based upon whether discrete financial information is available and reviewed regularly, whether those units constitute a business, and the extent of economic similarities between those reporting units for purposes of aggregation. The Company’s reporting units identified under ASC Topic 350-20-35-33 are at the component level, or one level below the operating segment level as defined under ASC Topic 280-10-50-10 “Segment Reporting - Disclosure.” The Company has three reporting units as of December 31, 2023 and March 31, 2023. The Duff-Norton reporting unit (which designs, manufactures and sources mechanical and electromechanical actuators and rotary unions) had goodwill of $9,699,000 at December 31, 2023 and March 31, 2023. The Rest of Products reporting unit (representing the hoist, chain, forgings, digital power, motion control, manufacturing, and distribution businesses) had goodwill of $308,693,000 and $306,988,000 at December 31, 2023 and March 31, 2023, respectively. The Precision Conveyance reporting unit (which represents high-precision conveying systems) had goodwill of $410,035,000 and $327,942,000 at December 31, 2023 and March 31, 2023, respectively. The goodwill associated with the fiscal 2024 acquisition of montratec, as described in Note 2, is included in the Precision Conveyance reporting unit. The Company has recorded adjustments to goodwill related to montratec during the quarter ended September 30, 2023. Refer to Note 2 for additional details related to these adjustments.

Refer to the 2023 10-K for information regarding our annual goodwill and indefinite lived trademark impairment evaluation. Future impairment indicators, such as declines in forecasted cash flows, may cause impairment charges. Impairment charges could be based on such factors as the Company’s stock price, forecasted cash flows, assumptions used, control premiums or other variables. There were no such indicators during the three and nine months ended December 31, 2023.

A summary of changes in goodwill during the nine months ended December 31, 2023 is as follows (in thousands):


Balance at April 1, 2023	$	644,629
Acquisition of montratec (Refer to Note 2)	78,943
Currency translation	4,855
Balance at December 31, 2023	728,427

Goodwill is recognized net of accumulated impairment losses of $113,174,000 as of December 31, 2023 and March 31, 2023, respectively.

Identifiable intangible assets acquired in a business combination are amortized over their estimated useful lives. Identifiable intangible assets are summarized as follows (in thousands):


	December 31, 2023						March 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Trademark	$	22,576	$	(7,582)	$	14,994	$	19,478	$	(6,315)	$	13,163
Indefinite lived trademark	46,672		—		46,672		46,338		—		46,338
Customer relationships	359,264		(104,850)		254,414		322,658		(88,685)		233,973
Acquired technology	112,894		(33,342)		79,552		96,291		(27,945)		68,346
Other	3,801		(3,116)		685		3,585		(2,868)		717
Total	$	545,207	$	(148,890)	$	396,317	$	488,350	$	(125,813)	$	362,537

The Company’s intangible assets that are considered to have finite lives are amortized. The weighted-average amortization periods are 13 years for trademarks, 17 years for customer relationships, 15 years for acquired technology, 5 years for other, and 16 years in total. Trademarks with a carrying value of $46,672,000 as of December 31, 2023 have an indefinite useful life and are therefore not being amortized.

Total amortization expense was $7,486,000 and $6,459,000 for the three months ended December 31, 2023 and 2022, respectively. Total amortization expense was $21,871,000 and $19,442,000 for the nine months ended December 31, 2023 and 2022, respectively. The increase in amortization expense is the result of the montratec acquisition and related intangible assets acquired. Based on the current amount of identifiable intangible assets and current exchange rates, the estimated annual amortization expense for each of the succeeding five years is expected to be approximately $30,000,000.

8. Derivative Instruments

The Company uses derivative instruments to manage selected foreign currency and interest rate exposures. The Company does not use derivative instruments for speculative trading purposes. All derivative instruments must be recorded on the balance sheet at fair value. For derivatives designated as cash flow hedges, changes in the fair value of the derivative is recorded as accumulated other comprehensive loss, or “AOCL,” and is reclassified to earnings when the underlying transaction has an impact on earnings. For foreign currency derivatives not designated as cash flow hedges, all changes in market value are recorded as a foreign currency exchange loss (gain) in the Company’s Consolidated Statements of Operations. The cash flow effects of derivatives are reported within net cash (used for) provided by operating activities on the Condensed Consolidated Statements of Cash Flows.

The Company is exposed to credit losses in the event of non-performance by the counterparties on its financial instruments. The counterparties have investment grade credit ratings. The Company anticipates that these counterparties will be able to fully satisfy their obligations under the contracts.

The Company's agreements with its counterparties contain provisions pursuant to which the Company could be declared in default of its derivative obligations. As of December 31, 2023, the Company had not posted any collateral related to these agreements. If the Company had breached any of these provisions as of December 31, 2023, it could have been required to settle its obligations under these agreements at amounts which approximate the December 31, 2023 fair values reflected in the table below. During the three and nine months ended December 31, 2023, the Company was not in default of any of its derivative obligations.

As of December 31, 2023, the Company had no derivatives designated as net investments or fair value hedges in accordance with FASB ASC Topic 815, “Derivatives and Hedging.”

The Company has a cross currency swap agreement that is designated as a cash flow hedge to hedge changes in the value of an intercompany loan to a foreign subsidiary due to changes in foreign exchange rates. This intercompany loan is related to the acquisition of Stahl Cranesystems GmbH ("STAHL"). As of December 31, 2023, the notional amount of this derivative is $99,378,000, and this contract matures on March 31, 2028. From its December 31, 2023 balance of AOCL, the Company expects to reclassify approximately $211,000 out of AOCL, and into foreign currency exchange loss (gain), during the next 12 months based on the contractual payments due under this intercompany loan.

The Company has foreign currency forward agreements that are designated as cash flow hedges to hedge a portion of forecasted inventory purchases denominated in foreign currencies. As of December 31, 2023, the notional amount of those derivatives was $4,591,000, and all contracts mature by September 30, 2024. From its December 31, 2023 balance of AOCL, the Company expects to reclassify approximately $68,000 out of AOCL during the next 12 months based on the expected payments for the goods purchased.

The Company's policy is to maintain a capital structure that is comprised of 50-70% of fixed rate long-term debt and 30-50% of variable rate long-term debt. The Company has two outstanding interest rate swap agreements in which the Company receives interest at a variable rate and pays interest at a fixed rate. The most recent interest rate swap agreement was entered into in fiscal year 2024 as a result of the additional debt from the montratec acquisition. The Company modified its historical interest rate swaps from LIBOR to SOFR in the first quarter of fiscal 2024. This modification had no impact on the Company's hedge accounting and hedge designation. These interest rate swap agreements are designated as cash flow hedges to hedge changes in interest expense due to changes in the variable interest rate of the Company's variable interest debt. The amortizing interest rate swaps mature by April 30, 2028 and had a total notional amount of $353,224,000 as of December 31, 2023. The effective portion of the changes in fair values of the interest rate swaps is reported in AOCL and will be reclassified to interest expense over the life of the swap agreements. From its December 31, 2023 balance of AOCL, the Company expects to reclassify approximately $5,638,000 of AOCL into interest and debt expense, during the next 12 months.

The following is the effect of derivative instruments on the Condensed Consolidated Statements of Operations for the three months ended December 31, 2023 and 2022 (in thousands):

Derivatives Designated as Cash Flow Hedges

Type of Instrument

Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives

Location of Gain or (Loss) Recognized in Income on Derivatives

Amount of Gain or (Loss) Reclassified from AOCL into Income

December 31, 2023

Foreign exchange contracts

(31)

Cost of products sold

(22)

December 31, 2023

Interest rate swaps

(1,958)

Interest expense

2,566

December 31, 2023

Cross currency swaps

(2,921)

Foreign currency exchange (gain) loss

(3,248)

December 31, 2022

Foreign exchange contracts

137

Cost of products sold

(64)

December 31, 2022

Interest rate swap

1,018

Interest expense

1,170

December 31, 2022

Cross currency swaps

(6,004)

Foreign currency exchange (gain) loss

(7,916)

The following is the effect of derivative instruments on the Condensed Consolidated Statements of Operations for the nine months ended December 31, 2023 and 2022 (in thousands):

Derivatives Designated as Cash Flow Hedges

Type of Instrument

Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives

Location of Gain or (Loss) Recognized in Income on Derivatives

Amount of Gain or (Loss) Reclassified from AOCL into Income

December 31, 2023

Foreign exchange contracts

(211)

Cost of products sold

(75)

December 31, 2023

Interest rate swaps

4,131

Interest expense

7,424

December 31, 2023

Cross currency swaps

(1,701)

Foreign currency exchange (gain) loss

(1,200)

December 31, 2022

Foreign exchange contracts

Cost of products sold

(153)

December 31, 2022

Interest rate swap

7,423

Interest expense

488

December 31, 2022

Cross currency swaps

5,623

Foreign currency exchange (gain) loss

3,464

The following is information relative to the Company’s derivative instruments in the Condensed Consolidated Balance Sheets (in thousands):


		Fair Value of Asset (Liability)
Derivatives Designated as Hedging Instruments	Balance Sheet Location	December 31, 2023		March 31, 2023
Foreign exchange contracts	Prepaid expenses and other	$	22	$	—
Foreign exchange contracts	Other Asset	—		136
Foreign exchange contracts	Accrued liabilities	(122)		(39)
Interest rate swap	Prepaid expenses and other	7,501		7,644
Interest rate swap	Other assets	433		3,218
Interest rate swap	Accrued liabilities	—		(387)
Interest rate swap	Other non current liabilities	(1,736)		—
Cross currency swap	Prepaid expenses and other	—		168
Cross currency swap	Accrued liabilities	(284)		—
Cross currency swap	Other non current liabilities	(4,222)		(2,270)

9. Debt

During fiscal 2024, the Company amended its New Revolving Credit Facility increasing the size of the New Revolving Credit Facility by $75,000,000 to a total of $175,000,000. The Company borrowed against the expanded New Revolving Credit Facility in May of fiscal 2024 to initially fund the montratec acquisition as described in Note 2. The Company subsequently borrowed additional funds in accordance with the Accordion feature under its existing Term Loan B facility to increase the principal amount of the Term Loan B facility by $75,000,000. The Company also borrowed an additional $45,000,000 under a new credit agreement secured by the Company's U.S. accounts receivable balances (the "AR Securitization Facility"). The total U.S. accounts receivable balances which secure the AR Securitization Facility total $72,736,000 as of December 31, 2023. The Company used the proceeds from the $75,000,000 Accordion borrowing and the $45,000,000 AR Securitization Facility to fully repay borrowings on the New Revolving Credit Facility prior to June 30, 2023.

The key terms of the new AR Securitization Facility are as follows:

•The AR Securitization Facility Agreement provides for revolving loans to be made up to a maximum principal amount of $55,000,000 of which $45,000,000 was drawn as of December 31, 2023.

•The AR Securitization Facility borrowings bear interest at a floating rate equal to a one-month secured overnight funding rate (SOFR) plus 10 basis points of credit spread adjustment, plus 110 basis points.

•The AR Securitization Facility borrowings are secured by the Company's U.S. accounts receivables totaling $72,736,000 at December 31, 2023.

•The AR Securitization Facility Agreement contains customary events of default (referred to as “Amortization Events.”)

•Amounts drawn under the AR Securitization Facility may remain outstanding until the maturity date of the AR Securitization Facility on June 19, 2026. Prior to the maturity date, the Company is only required to repay principal to the extent necessary to maintain borrowing base compliance, unless an Amortization Event occurs.

As of December 31, 2023, there have been no Amortization Events triggered in the AR Securitization Facility. The Company has both the ability and intent to have the AR Securitization Facility remain outstanding for the next 12-months. As such, the Company has classified the full $45,000,000 outstanding borrowings under the AR Securitization Facility as long-term debt at December 31, 2023.

In addition to the above, the Company amended the variable interest component of its Term Loan B and New Revolving Credit Facility to transition from LIBOR to SOFR.

The outstanding principal balance of the Term Loan B facility was $497,560,000 as of December 31, 2023, which includes $75,000,000 in principal balance from the Accordion exercised in the first quarter of fiscal 2024 as described above. The Company made $40,000,000 in principal payments on the Term Loan B facility during the nine months ended December 31, 2023 of which $4,585,000 was required. The Company is obligated to make $6,113,000 of principal payments on the Term Loan B facility over the next 12 months plus applicable Excess Cash Flow ("ECF") payments, if required, however, plans to pay down approximately $50,000,000 in principal payments in total during such 12 month period. This amount has been recorded within the current portion of long-term debt on the Company's Condensed Consolidated Balance Sheet with the remaining balance recorded as long-term debt. Refer to the 2023 10-K for further details on the Company's Term Loan B facility.

There were no outstanding borrowings and $15,740,000 in outstanding letters of credit issued against the New Revolving Credit Facility as of December 31, 2023. The outstanding letters of credit as of December 31, 2023 consisted of $171,000 in commercial letters of credit and $15,569,000 of standby letters of credit.

The gross balance of deferred financing costs on the Term Loan B facility was $7,845,000, which includes $2,414,000 from the Accordion exercises, as of December 31, 2023 and $6,323,000, which includes $892,000 from the Accordion exercise, as of March 31, 2023. The accumulated amortization balances were $2,663,000 and $1,815,000 as of December 31, 2023 and March 31, 2023, respectively. The gross balance of deferred financing costs associated with the AR Securitization Facility was $536,000 with an accumulated amortization balance of $104,000 as of December 31, 2023.

The gross balance of deferred financing costs associated with the New Revolving Credit Facility is $4,828,000 as of December 31, 2023 and $4,027,000 as of March 31, 2023, respectively, which are included in Other assets on the Condensed Consolidated Balance Sheet. The $801,000 increase in Fiscal 2024 relates to fees paid to increase the size of the New Revolving Credit Facility to $175,000,000 as described above. The accumulated amortization balances were $2,385,000 and $1,611,000 as of December 31, 2023 and March 31, 2023, respectively.

The Company has a finance lease for a manufacturing facility in Hartland, WI under a 23-year lease agreement which terminates in 2035. The outstanding balance on the finance lease obligation is $13,093,000 as of December 31, 2023 of which $652,000 has been recorded within the Current portion of long-term debt and the remaining balance recorded within the Term loan, AR securitization facility and finance lease obligations on the Company's Condensed Consolidated Balance Sheet. See Note 15 for further details.

Unsecured and uncommitted lines of credit are available to meet short-term working capital needs for certain of our subsidiaries operating outside of the U.S. The lines of credit are available on an offering basis, meaning that transactions under the line of credit will be on such terms and conditions, including interest rate, maturity, representations, covenants and events of default, as mutually agreed between our subsidiaries and the local bank at the time of each specific transaction. As of December 31, 2023, unsecured credit lines totaled approximately $2,428,000, of which nothing was drawn. In addition, unsecured lines of

$13,541,000 were available for bank guarantees issued in the normal course of business of which $10,758,000 was utilized as of December 31, 2023.

Refer to the Company’s consolidated financial statements included in its 2023 10-K for further information on its debt arrangements.

10. Net Periodic Benefit Cost

The following table sets forth the components of net periodic pension cost for the Company’s defined benefit pension plans (in thousands):


	Three Months Ended				Nine Months Ended
	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
Service costs	$	136	$	199	$	389	$	536
Interest cost	3,419		2,848		10,351		8,537
Expected return on plan assets	(2,867)		(2,709)		(8,759)		(8,130)
Net amortization	62		192		266		607
Settlement	$	4,639	$	—	$	4,720	$	—
Net periodic pension (benefit) cost	$	5,389	$	530	$	6,967	$	1,550

Components of the net benefit costs other than the service cost component are recorded in Other (income) expense, net on the Condensed Consolidated Statements of Operations. Service costs are recorded as part of Income from operations.

During the three months ended December 31, 2023, certain employees in one of the Company's U.S. pension plans accepted an offer to settle their pension obligation with a lump sum payment. These lump sum settlements are one of the steps the Company is taking to terminate the plan by transferring the liabilities to a third-party. As a result, the Company recorded a settlement charge in the amount $4,599,000 which was recorded in Other (income) expense, net on the Condensed Consolidated Statements of Operations. The Company expects to complete the plan termination during fiscal year 2025, at which point the Company will record another settlement charge.

The Company currently plans to contribute approximately $6,908,000 to its pension plans in fiscal 2024.

For additional information on the Company’s defined benefit pension and postretirement benefit plans, refer to the consolidated

financial statements included in the 2023 10-K.

11. Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands):


	Three Months Ended				Nine Months Ended
	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
Numerator for basic and diluted earnings per share:
Net income (loss)	$	9,728	$	12,029	$	34,816	$	34,534

Denominators:
Weighted-average common stock outstanding – denominator for basic EPS	28,744		28,626		28,711		28,597
Effect of dilutive employee stock options and other share-based awards	247		152		268		170
Adjusted weighted-average common stock outstanding and assumed conversions – denominator for diluted EPS	28,991		28,778		28,979		28,767

Stock options with respect to 824,000 and 744,000 common shares for the three and nine months ended December 31, 2023, respectively, and 715,000 for both the three and nine months ended December 31, 2022, were not included in the computation of diluted income per share because they were antidilutive. For the three and nine months ended December 31, 2023 and December 31, 2022 contingently issuable common shares of 165,000 and 179,000, respectively, were excluded because a performance condition had not yet been met.

The Company grants share based compensation to eligible participants under the 2016 Long Term Incentive Plan, as Amended and Restated in June 2019 ("2016 LTIP"). The total number of shares of common stock with respect to which awards may be granted under the 2016 LTIP were increased by 2,500,000 as a result of the June 2019 amendment and restatement. Shares not previously authorized for issuance under any of the prior stock plans and any shares not issued or subject to outstanding awards under the prior stock plans are still available for issuance.

During fiscal 2024, the Company determined that the performance condition on its fiscal 2022 performance shares would not be fully met. The Company has adjusted its stock-based compensation expense accordingly in fiscal 2024.

During fiscal 2023, the Company repurchased 31,000 shares of its common stock at an aggregate cost of $1,001,000 in accordance with the Company's previously adopted share repurchase program. The value of the shares purchased are reflected as Treasury stock on the Company's Condensed Consolidated Balance Sheet as of March 31, 2023. There were no such purchases in fiscal 2024.

During the first nine months of fiscal 2024, there were 21,000 shares of stock issued upon the exercise of stock options that were issued under the Company’s 2016 LTIP. During the fiscal year ended March 31, 2023, 133,000 shares of restricted stock units vested and were issued.

On January 22, 2024, the Company's Board of Directors declared a dividend of $0.07 per common share. The dividend will be paid on February 20, 2024 to shareholders of record on February 9, 2024. The dividend payment is expected to be approximately $2,015,000.

Refer to the Company’s consolidated financial statements included in its 2023 10-K for further information on its earnings per share and stock plans.

12. Loss Contingencies

From time to time, the Company is named a defendant in legal actions arising out of the normal course of business. The Company is not a party to any pending legal proceeding other than ordinary, routine litigation incidental to our business. The Company does not believe that any of its pending litigation will have a material impact on its business.

Accrued general and product liability costs are actuarially estimated reserves based on amounts determined from loss reports, individual cases filed with the Company, and an amount for losses incurred but not reported. The aggregate amounts of reserves were $19,350,000 (gross of estimated insurance recoveries of $7,496,000) as of December 31, 2023, of which $14,750,000 is included in Other non current liabilities and $4,600,000 in Accrued liabilities. The liability for accrued general and product liability costs are funded by investments in marketable securities (see Note 6).

The following table provides a reconciliation of the beginning and ending balances for accrued general and product liability (in thousands):


	December 31, 2023		March 31, 2023
Accrued general and product liability, beginning of period	$	21,103	$	22,575
Estimated insurance recoveries	(773)		(889)
Add provision for claims	1,251		3,025
Deduct payments for claims	(2,231)		(3,608)
Accrued general and product liability, end of period	$	19,350	$	21,103

Estimated insurance recoveries	(7,496)		(8,272)
Net accrued general and product liability, end of period	$	11,854	$	12,831

The per occurrence limits on the self-insurance for general and product liability coverage to Columbus McKinnon through its wholly-owned captive insurance company were $2,000,000 from inception through fiscal 2003 and $3,000,000 for fiscal 2004 and thereafter. In addition to the per occurrence limits, the Company’s coverage is also subject to an annual aggregate limit, applicable to losses only. These limits range from $2,000,000 to $6,000,000 for each policy year from inception through fiscal 2024. The Company also purchases excess general and product liability insurance up to an aggregate $75,000,000 limit.

Asbestos

Like many industrial manufacturers, the Company is involved in asbestos-related litigation. In continually evaluating costs relating to its estimated asbestos-related liability, the Company reviews, among other things, the incidence of past and recent claims, the historical case dismissal rate, the mix of the claimed illnesses and occupations of the plaintiffs, its recent and historical resolution of the cases, the number of cases pending against it, the status and results of broad-based settlement discussions, and the number of years such activity might continue. Based on this review, the Company has estimated its share of liability to defend and resolve probable asbestos-related personal injury claims. This estimate is highly uncertain due to the limitations of the available data and the difficulty of forecasting with any certainty the numerous variables that can affect the range of the liability. The Company will continue to study the variables in light of additional information in order to identify trends that may become evident and to assess their impact on the range of liability that is probable and estimable.

Based on actuarial information, the Company has estimated its net asbestos-related aggregate liability including related legal costs to range between $4,900,000 and $8,900,000, net of insurance recoveries, using actuarial parameters of continued claims for a period of 38 years from December 31, 2023. The Company has estimated its asbestos-related aggregate liability that is probable and estimable, net of insurance recoveries, in accordance with U.S. generally accepted accounting principles approximates $6,414,000. The Company has reflected the liability gross of insurance recoveries of $7,496,000 as a liability in the Condensed Consolidated Balance Sheet as of December 31, 2023. The recorded liability does not consider the impact of any potential favorable federal legislation. This liability will fluctuate based on the uncertainty in the number of future claims that will be filed and the cost to resolve those claims, which may be influenced by a number of factors, including the outcome of the ongoing broad-based settlement negotiations, defensive strategies, and the cost to resolve claims outside the broad-based settlement program. Of this amount, management expects to incur asbestos liability payments of approximately $2,700,000 over the next 12 months. Because payment of the liability is likely to extend over many years, management believes that the potential additional costs for claims will not have a material effect on the financial condition of the Company or its liquidity, although the effect of any future liabilities recorded could be material to earnings in a future period.

A share of the Company’s previously incurred asbestos-related expenses and future asbestos-related expenses are covered by pre-existing insurance policies. The Company had been engaged in a legal action against the insurance carriers for those policies to recover past expenses and future costs incurred. The Company came to an agreement with the insurance carriers to settle its case against them for recovery of a portion of past costs and future costs for asbestos-related legal defense costs. The agreement was finalized during the quarter ended September 30, 2020. The terms of the settlement require the carriers to pay gross defense costs prior to retro-premiums of 65% for future asbestos-related defense costs subject to an annual cap of $1,650,000 for claims covered by the settlement.

Further, the insurance carriers are expected to cover 100% of indemnity costs related to all covered cases. Estimates of the future cost sharing have been included in the loss reserve calculation as of December 31, 2023 and March 31, 2023. The Company has recorded a receivable for the estimated future cost sharing in Other assets in the Condensed Consolidated Balance Sheet at December 31, 2023 in the amount of $7,496,000, which offsets its asbestos reserves.

In addition, one of the Company's subsidiaries, Magnetek, Inc. ("Magnetek"), has been named, along with multiple other defendants, in asbestos-related lawsuits associated with business operations previously acquired but which are no longer owned. During Magnetek's ownership, none of the businesses produced or sold asbestos-containing products. For such claims, Magnetek is uninsured and either contractually indemnified against liability, or contractually obligated to defend and indemnify the purchaser of these former business operations. The Company aggressively seeks dismissal from these proceedings. The asbestos-related liability including legal costs is estimated to be approximately $776,000 which has been reflected as a liability in the Condensed Consolidated Balance Sheet at December 31, 2023.

Product Liability

The Company is also involved in other unresolved legal actions that arise in the normal course of business. The most prevalent of these unresolved actions involve disputes related to product design, manufacture and performance liability. The Company's estimation of its product-related aggregate liability that is probable and estimable, in accordance with U.S. generally accepted accounting principles approximates $4,664,000, which has been reflected as a liability in the Condensed Consolidated Balance

Sheet as of December 31, 2023. In some cases, the Company cannot reasonably estimate a range of loss because there is insufficient information regarding the matter. Management believes that the potential additional costs for claims will not have a material effect on the financial condition of the Company or its liquidity, although the effect of any future liabilities recorded could be material to earnings in a future period.

Litigation-Other

In October 2010, Magnetek received a request for indemnification from Power-One, Inc. ("Power-One") for an Italian tax matter arising out of the sale of Magnetek's power electronics business to Power-One in October 2006. With a reservation of rights, Magnetek affirmed its obligation to indemnify Power-One for certain pre-closing taxes. The sale included an Italian company, Magnetek, S.p.A., and its wholly owned subsidiary, Magnetek Electronics (Shenzhen) Co. Ltd. (the “Power-One China Subsidiary”). The tax authority in Arezzo, Italy, issued a notice of audit report in September 2010 wherein it asserted that the Power-One China Subsidiary had its administrative headquarters in Italy and, therefore, it should be considered resident in Italy and subject to taxation in Italy. In November 2010, the tax authority issued a notice of tax assessment for the period of July 2003 to June 2004, alleging that taxes of approximately $2,100,000 (Euro 1,900,000), plus interest, were due in Italy on taxable income earned by the Power-One China Subsidiary during this period. In addition, the assessment alleges potential penalties in the amount of approximately $2,400,000 (Euro 2,200,000) for the alleged failure of the Power-One China Subsidiary to file its Italian tax return. The Power-One China Subsidiary filed its response with the provincial tax commission of Arezzo, Italy in January 2011. A hearing before the Tax Court was held in July 2012 on the tax assessment for the period of July 2003 to June 2004. In September 2012, the Tax Court ruled in favor of the Power-One China Subsidiary dismissing the tax assessment for the period of July 2003 to June 2004. In February 2013, the tax authority filed an appeal of the Tax Court's September 2012 ruling. The Regional Tax Commission of Florence heard the appeal of the tax assessment dismissal for the period of July 2003 to June 2004 and thereafter issued its ruling finding in favor of the tax authority. Magnetek believed the court’s decision was based upon erroneous interpretations of the applicable law and appealed the ruling to the Italian Supreme Court in April 2015. In April 2022, the Supreme Court upheld the appeal in favor of Power-One.

The tax authority in Arezzo, Italy also issued a tax inspection report in January 2011 for the periods July 2002 to June 2003 (fiscal period 2002/2003) and July 2004 to December 2006 (fiscal periods 2004/2005 and 2005/2006) claiming that the Power-One China Subsidiary failed to file Italian tax returns for the reported periods. In August 2012, the tax authority in Arezzo, Italy issued four notices of tax assessment for the periods July 2002 to June 2003 and July 2004 to December 2006, alleging that taxes of approximately $7,400,000 (Euro 6,700,000) were due in Italy on taxable income earned by the Power-One China Subsidiary together with an allegation of potential penalties in the amount of approximately $3,100,000 (Euro 2,800,000) for the alleged failure of the Power-One China Subsidiary to file its Italian tax returns.

On June 3, 2015, the Tax Court, ruled in favor of the Power-One China Subsidiary dismissing the tax assessments for the periods of July 2002 to June 2003 and July 2004 to December 2006. On July 27, 2015, the tax authority filed appeals of the Tax Court's ruling of June 3, 2015. In May 2016, the Regional Tax Court of Florence rejected the appeals of the tax authority and at the same time canceled the notices of assessment for the fiscal years of 2004/2005 and 2005/2006. In December 2016, the Power-One China Subsidiary was served by the Italian Revenue Agency with two appeals to the Italian Supreme Court regarding the two positive judgments on the tax assessments for the fiscal periods 2004/2005 and 2005/2006. In February 2017 the Power-One China Subsidiary filed two memorandum before the Italian Supreme Court in response to the appeals made by the tax authority against the positive judgments on the tax assessments for fiscal years 2004/2005 and 2005/2006.

In March 2017, the Regional Tax Court of Florence rejected the appeal of the assessment for 2006 fiscal year (period July 2006-December 2006). In October 2017, the Power-One China Subsidiary was served by the Italian Revenue Agency with an appeal to the Italian Supreme Court against the positive judgment on the tax assessment for fiscal year 2006. In November 2017 the Power-One China Subsidiary filed a memorandum before the Italian Supreme Court in response to the appeal made by the tax authority against the positive judgment on the tax assessment for fiscal year 2006. In March 2018, the Regional Tax Court of Florence rejected the appeal of the assessment for 2002/2003 fiscal year. In October 2018 the Power-One China Subsidiary was served by the Italian Revenue Agency with an appeal to the Italian Supreme Court against the positive judgment on the tax assessment for fiscal year 2002/2003. In November 2018 the Power-One China Subsidiary filed a memorandum with the Italian Supreme Court in response to the appeal made by the tax authority. The Supreme Court upheld the appeals of the Italian Tax Authority and remitted the proceedings back to the Regional Tax Court for a new evaluation of the substance of the dispute.

In December 2022 the Power One China Subsidiary resumed the proceedings concerning the tax assessments for fiscal years 2002/2003 and 2006 before the Regional Tax Court. A hearing was held before the Regional Tax Court in April and May of 2023, in two separate decisions, the court ruled in favor of the Company. The tax authority appealed this decision on December 6, 2023, and the Company filed the relevant counter claims in January of 2024.

In March 2023 the Power One China Subsidiary resumed the proceedings concerning the tax assessments for fiscal years 2004/2005 and 2005/2006 before the Regional Tax Court. The hearing on this matter is expected to be held in February 2024.

The Company believes it will be successful and does not expect to incur a liability related to these assessments.

In September of 2017, Magnetek received a request for defense and indemnification from Monsanto Company, Pharmacia, LLC, and Solutia, Inc. (collectively, “Monsanto”) with respect to: (1) lawsuits brought by plaintiffs claiming that Monsanto manufactured polychlorinated biphenyls ("PCBs"), exposure to which allegedly caused injury to plaintiffs; and (2) lawsuits brought by municipalities and municipal entities claiming that Monsanto should be responsible for a variety of damages due to the presence of PCBs in bodies of water in those municipalities and/or in water treated by those municipal entities. Monsanto claims to be entitled to defense and indemnification from Magnetek under a so-called “Special Undertaking” apparently executed by Magnetek’s predecessor Universal Manufacturing ("Universal") in January of 1972, which purportedly required Universal to defend and indemnify Monsanto from liabilities “arising out of or in connection with the receipt, purchase, possession, handling, use, sale or disposition of” PCBs by Universal.

Magnetek has declined Monsanto’s tender, and believes that it has meritorious legal and factual defenses to the demands made by Monsanto. Magnetek is vigorously defending against those demands and commenced litigation in New Jersey to, among other things, declare the Special Undertaking void and unenforceable. Monsanto has, in turn, commenced an action to enforce the Special Undertaking in Missouri and joined five additional companies as co-defendants in that Missouri action.

The New Jersey action was recently dismissed in favor of the Missouri action. Magnetek has appealed that decision and intends to continue to vigorously prosecute its New Jersey declaratory judgment action, and to defend against Monsanto’s action against it. The Company cannot reasonably estimate a potential range of loss with respect to Monsanto’s tender because there is insufficient information regarding the underlying matters. Management believes, however, that the potential additional legal costs related to such matters will not have a material effect on the financial condition of the Company or its liquidity, although the effect of any future liabilities recorded could be material to earnings in a future period.

The Company had previously filed suit against Travelers in District Court seeking coverage under insurance policies in the name of Universal. In July 2019, the District Court ruled that Travelers is obligated to defend Magnetek under these policies in connection with Magnetek's litigation against Monsanto. The Court held that Monsanto's claims against Magnetek fall within the insuring agreement of the Travelers policies and that none of the policy exclusions precluded the possibility of coverage. The Court also held that Travelers prior settlements with other insureds under the policies did not cut off or release Magnetek's rights under the policies. Travelers moved for reconsideration which motion was denied. Travelers is currently defending the Company in its litigation with Monsanto.

The Company is also engaged in similar insurance coverage litigation against Transportation Insurance Company in the Circuit Court of Cook County, Illinois. That suit is presently stayed due to the bankruptcy of Velsicol Chemical, LLC, a third-party indemnitor of TIC and Travelers.

Environmental Matters

Along with other manufacturing companies, the Company is subject to various federal, state and local laws relating to the protection of the environment. To address the requirements of such laws, the Company has adopted a corporate environmental protection policy which provides that all of its owned or leased facilities shall, and all of its employees have the duty to, comply with all applicable environmental regulatory standards, and the Company utilizes an environmental auditing program for its facilities to ensure compliance with such regulatory standards. The Company has also established managerial responsibilities and internal communication channels for dealing with environmental compliance issues that may arise in the course of its business. Because of the complexity and changing nature of environmental regulatory standards, it is possible that situations will arise from time to time requiring the Company to incur expenditures in order to ensure environmental regulatory compliance. However, the Company is not aware of any environmental condition or any operation at any of its facilities, either individually or in the aggregate, which would cause expenditures having a material adverse effect on its results of operations, financial condition or cash flows and, accordingly, has not budgeted any material capital expenditures for environmental compliance for fiscal 2024.

In 1986, Magnetek acquired the stock of Universal Manufacturing Corporation (“Universal”) from a predecessor of Fruit of the Loom (“FOL”), and the predecessor agreed to indemnify Magnetek against certain environmental liabilities arising from pre-acquisition activities at a facility in Bridgeport, Connecticut. Environmental liabilities covered by the indemnification agreement included completion of additional cleanup activities, if any, at the Bridgeport facility and defense and

indemnification against liability for potential response costs related to offsite disposal locations. Magnetek's leasehold interest in the Bridgeport facility was assigned to the buyer in connection with the sale of Magnetek's transformer business in June 2001. FOL, the successor to the indemnification obligation, filed a petition for Reorganization under Chapter 11 of the Bankruptcy Code in 1999 and Magnetek filed a proof of claim in the proceeding for obligations related to the environmental indemnification agreement. Magnetek believes that FOL had substantially completed the clean-up obligations required by the indemnification agreement prior to the bankruptcy filing. In November 2001, Magnetek and FOL entered into an agreement involving the allocation of certain potential tax benefits and Magnetek withdrew its claims in the bankruptcy proceeding. Magnetek further believes that FOL's obligation to the state of Connecticut was not discharged in the reorganization proceeding.

In January 2007, the Connecticut Department of Environmental Protection (“DEP”) requested parties, including Magnetek, to submit reports summarizing the investigations and remediation performed to date at the site and the proposed additional investigations and remediation necessary to complete those actions at the site. DEP requested additional information relating to site investigations and remediation. Magnetek and the DEP agreed to the scope of the work plan in November 2010. The Company has recorded a liability of $314,000 included in the amount specified above, related to the Bridgeport facility, representing the best estimate of future site investigation costs and remediation costs which are expected to be incurred in the future.

For all of the currently known environmental matters, the Company has accrued as of December 31, 2023 a total of $727,000 which, in our opinion, is sufficient to deal with such matters. The Company is not aware of any environmental condition or any operation at any of its facilities, either individually or in the aggregate, which would cause expenditures to have a material adverse effect on its results of operations, financial condition or cash flows and, accordingly, has not budgeted any material capital expenditures for environmental compliance for fiscal 2024.

13. Income Taxes

Income tax expense (benefit) as a percentage of income (loss) from continuing operations before income tax expense was 29% and 28% in the three months ended December 31, 2023 and December 31, 2022, respectively, and 26% and 35% in the nine months ended December 31, 2023 and December 31, 2022, respectively. Typically these percentages vary from the U.S. statutory rate of 21% primarily due to varying statutory tax rates at the Company's foreign subsidiaries, and the jurisdictional mix of income for these subsidiaries.

During the nine months ended December 31, 2022, the rate was unfavorably impacted 5 percentage points due to settlement of income tax assessments related to tax periods prior to the Company’s acquisition of Stahl Cranesystems GmbH (“STAHL"). In accordance with the tax indemnification clause of the share purchase agreement, the Company received full reimbursement from STAHL’s prior owner which was recorded as a gain in Other (income) expense, net on the Condensed Consolidated Statements of Operations during the period. The tax rate for the nine months ended December 31, 2022 also reflects an unfavorable impact of 4 percentage points due to the recording of a U.S. state tax valuation allowance. The valuation allowance primarily relates to changes in the Company’s expectations regarding its ability to more likely than not utilize certain state net operating losses prior to their expiration.

The Company estimates that the effective tax rate related to continuing operations will be approximately 24% to 26% for fiscal 2024.

Refer to the Company’s consolidated financial statements included in its 2023 10-K for further information on income taxes.

14. Changes in Accumulated Other Comprehensive Loss

Changes in AOCL by component for the three and nine months ended December 31, 2023 are as follows (in thousands):


	Three months ended December 31, 2023
	Retirement Obligations		Foreign Currency		Change in Derivatives Qualifying as Hedges		Total
Beginning balance net of tax	$	(12,966)	$	(39,134)	$	7,385	$	(44,715)
Other comprehensive income (loss) before reclassification	1,094		13,339		(4,910)		9,523
Amounts reclassified from other comprehensive loss	3,501		—		704		4,205
Net current period other comprehensive income (loss)	4,595		13,339		(4,206)		13,728
Ending balance net of tax	$	(8,371)	$	(25,795)	$	3,179	$	(30,987)


	Nine Months Ended December 31, 2023
	Retirement Obligations		Foreign Currency		Change in Derivatives Qualifying as Hedges		Total
Beginning balance net of tax	$	(12,800)	$	(32,352)	$	7,109	$	(38,043)
Other comprehensive income (loss) before reclassification	773		6,557		2,219		9,549
Amounts reclassified from other comprehensive loss	3,656		—		(6,149)		(2,493)
Net current period other comprehensive income (loss)	4,429		6,557		(3,930)		7,056
Ending balance net of tax	$	(8,371)	$	(25,795)	$	3,179	$	(30,987)

Details of amounts reclassified out of AOCL for the three months ended December 31, 2023 are as follows (in thousands):


Details of AOCL Components	Amount reclassified from AOCL		Affected line item on Condensed Consolidated Statement of Operations






Net amortization of prior service cost and pension settlement expense
	$	4,652
	4,652		Total before tax
	(1,151)		Tax (benefit) expense
	$	3,501	Net of tax

Change in derivatives qualifying as hedges
	$	29	Cost of products sold
	(3,389)		Interest expense
	4,290		Foreign currency
	930		Total before tax
	(226)		Tax (benefit) expense
	$	704	Net of tax

Details of amounts reclassified out of AOCL for the nine months ended December 31, 2023 are as follows (in thousands):


Details of AOCL Components	Amount reclassified from AOCL		Affected line item on Condensed Consolidated Statement of Operations






Net amortization of prior service cost and pension settlement expense
	$	4,840
	4,840		Total before tax
	(1,184)		Tax (benefit) expense
	$	3,656	Net of tax

Change in derivatives qualifying as hedges
	$	99	Cost of products sold
	(9,807)		Interest expense
	1,585		Foreign currency
	(8,123)		Total before tax
	1,974		Tax (benefit) expense
	$	(6,149)	Net of tax

These AOCL components are included in the computation of net periodic pension cost. (See Note 10 for additional details.)

15. Leases

The Company’s lease arrangements generally include real estate (manufacturing facilities, sales offices, distribution centers, warehouses), vehicles, and equipment. Leases with a term greater than one year are recognized on the Consolidated Balance Sheet; the Company has elected not to recognize leases with terms of one year or less on the Consolidated Balance Sheet. Lease obligations and their corresponding ROU assets are recorded based on the present value of lease payments over the expected lease term. The Company recognizes lease expense on a straight-line basis over the lease term.

The Company's leases have lease terms ranging from 1 to 23 years, some of which include options to extend or terminate the lease. The exercise of lease renew all options is at the Company’s sole discretion. When deemed reasonably certain of exercise, the renewal options are included in the determination of the lease term. The Company’s lease agreements do not contain material residual value guarantees or any material restrictive covenants.

The following table illustrates the lease-related assets and liabilities recorded on the Condensed Consolidated Balance Sheet (in thousands):


	December 31, 2023		March 31, 2023
Operating leases:
Other assets	$	65,424	$	53,551

Accrued liabilities	9,511		7,966
Other non current liabilities	58,763		46,524
Total operating liabilities	$	68,274	$	54,490

Finance lease:
Net property, plant, and equipment	$	11,846	$	12,597

Current portion of long-term debt and finance lease obligation	652		604
Term loan and finance lease obligations	12,441		12,937
Total finance liabilities	$	13,093	$	13,541

Operating lease expense of $3,216,000 and $9,429,000 and $2,323,000 and $6,810,000 for the three and nine months ended December 31, 2023 and December 31, 2022, respectively, is included in Income from operations on the Condensed Consolidated Statements of Operations. Short-term lease expense, sublease income, and variable lease expenses were not material for the three and nine months ended December 31, 2023 and December 31, 2022, respectively. Finance lease expense of $250,000 and $751,000 for both the three and nine months ended December 31, 2023 and December 31, 2022, respectively, is included in Income from operations on the Condensed Consolidated Statements of Operations. Interest and debt expense related to the finance lease of $149,000 and $451,000 and $156,000 and $470,000 is included the Company's Condensed Consolidated Statements of Operations in the three and nine months ended December 31, 2023 and December 31, 2022, respectively.

Supplemental cash flow information related to leases is as follows (in thousands):


	Nine Months Ended December 31,
	2023		2022
Cash paid for amounts included in the measurement of operating lease liabilities	$	7,771	$	6,678
Cash paid for amounts included in the measurement of finance lease liabilities	$	898	$	872
ROU assets obtained in exchange for new operating lease liabilities	$	17,442	$	8,592

16. Effects of New Accounting Pronouncements

Topics recently adopted

In December 2022, the FASB issued ASU 2022-06, "Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848" from December 31, 2022 to December 31, 2024, which is superseding the date from ASU No. 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." This ASU is elective and is relief to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Optional expedients are provided for contract modification accounting under topics such as debt, leases, and derivatives. The optional amendments are effective for all entities as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through December 31, 2024. The Company modified its interest rate swap contracts during the quarter to transition from LIBOR to SOFR. The adoption of this update did not have a material impact on the Company’s consolidated financial statements.

In October 2021, the FASB issued ASU No. 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers." The ASU amends ASC 805 to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination and is intended to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those years, with early adoption permitted. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company adopted this standard effective April 1, 2023 and applied it in the purchase accounting for montratec. The adoption did not have a material impact on the Company's consolidated financial statements.

Topics Not Yet Adopted

We consider the applicability and impact of all ASUs. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The ASU is intended to provide increased transparency about income tax information through improvements to income tax disclosures related to the rate reconciliation and income taxes paid. The Company is currently assessing the impact this ASU will have on the footnotes of its annual financial statements. The Company plans to adopt this standard in fiscal 2026 when required.

ASUs not listed were assessed and determined to be either not applicable, or had or are expected to have an immaterial impact on our financial statements and related disclosures.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

Executive Overview

The Company is a leading worldwide designer, manufacturer and marketer of intelligent motion solutions, including motion control products, technologies, automated systems and services, that efficiently and ergonomically move, lift, position and secure materials. Our key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. These are highly relevant, professional-grade solutions that solve customers’ critical material handling requirements.

Founded in 1875, we have grown to our current size and leadership position through organic growth and acquisitions. We developed our leading market position over our 149-year history by emphasizing technological innovation, manufacturing excellence and superior customer service. In accordance with our strategic framework, we are building out our business system (CMBS) and growth framework to be market-led, customer-centric, and operationally excellent with our people and values at the core. We believe this will transform Columbus McKinnon into a top-tier Intelligent Motion Solutions company. We expect our strategy will enhance shareholder value by expanding EBITDA margins and return on invested capital ("ROIC").

Our revenue base is geographically diverse with approximately 44% derived from customers outside the U.S. for the nine months ended December 31, 2023. We believe this diversity balances the impact of changes that occur in local economies, as well as benefits the Company by providing access to growing emerging markets. We monitor both U.S. and Eurozone Industrial Capacity Utilization statistics as well as the ISM Production Index as indicators of anticipated demand for our products. In addition, we continue to monitor the potential impact of other global and U.S. trends including, industrial production, trade tariffs, raw material cost inflation, interest rates, foreign currency exchange rates, and activity of end-user markets around the globe.

From a strategic perspective, we are investing in new products as we focus on our greatest opportunities for growth. We maintain a strong North American market share with significant leading market positions in hoists, lifting and sling chain, forged attachments, actuators, precision conveyors and digital power and motion control systems for the material handling industry. We seek to maintain and enhance our market share by focusing our sales and marketing activities toward select North American and global market sectors including general industrial, energy, automotive, heavy OEM, entertainment, construction and infrastructure, life sciences food and beverage, e-commerce and consumer products.

On May 31, 2023, the Company completed its acquisition of montratec GmbH ("montratec"), a leading automation solutions company that designs and develops intelligent automation and transport systems for interlinking industrial production and logistics processes. montratec product offerings complement both Dorner and Garvey, and further the Company's shift to intelligent motion and serve as a platform to expand capabilities in advanced, higher technology automation solutions.

Regardless of the economic climate and point in the economic cycle, we constantly explore ways to increase operating margins as well as further improve our productivity and competitiveness. We have specific initiatives to reduce lead-times, improve on-time deliveries, reduce warranty costs, and improve material and factory productivity. The initiatives are being driven by the implementation of our business operating system, CMBS. We are working to achieve these strategic initiatives through business simplification, operational excellence, and profitable growth initiatives. We believe these initiatives will enhance future operating margins.

Our principal raw materials and components purchases were approximately $365 million in fiscal 2023 (or 61% of Cost of product sold) and include steel, consisting of rod, wire, bar, structural, and other forms of steel; electric motors; bearings; gear reducers; castings; steel and aluminum enclosures and wire harnesses; electro-mechanical components; and standard variable drives and controls. These commodities are all available from multiple sources. We purchase most of these raw materials and components from a limited number of strategic and preferred suppliers under agreements which are negotiated on a company-wide basis through our global purchasing group. Currently, we are seeing global inflation moderate and availability improve for select raw materials and components.

We operate in a highly competitive and global business environment. We see a variety of opportunities in our markets and geographies, including trends toward automation and increasing labor productivity and the expansion of market opportunities in Asia and other emerging markets. While we execute our long-term growth strategy, we are supported by our strong free cash flow as well as our liquidity position and flexible debt structure.

Results of Operations

Three months ended December 31, 2023 and December 31, 2022

Net sales in the three months ended December 31, 2023 were $254,143,000, up $23,773,000 or 10.3% from the three months ended December 31, 2022 net sales of $230,370,000. Net sales were positively impacted by $15,535,000 of revenue from the montratec acquisition, $6,477,000 due to price increases, offset by 2,403,000 of unfavorable sales volume. Foreign currency translation favorably impacted sales by $4,164,000 for the three months ended December 31, 2023.

Gross profit in the three months ended December 31, 2023 was $93,897,000, an increase of $11,853,000 or 14.4% from the three months ended December 31, 2022 gross profit of $82,044,000. Gross profit margin was 36.9% in the fiscal 2024 third quarter compared to 35.6% in the fiscal 2023 third quarter. The increase in gross profit was due to $6,736,000 as a result of the acquisition of montratec, $4,562,000 of price increases net of manufacturing costs changes including inflation and $904,000 of favorable product liability reserve adjustments. These increases were offset by unfavorable sales volume mix of $1,179,000 and $585,000 of current year business realignment costs. The translation of foreign currencies had a $1,415,000 favorable impact on gross profit in the three months ended December 31, 2023.

Selling expenses were $26,552,000 and $25,424,000, or 10.4% and 11.0% of net sales, in the fiscal 2024 and 2023 third quarters, respectively. Selling expense increased by $2,131,000 due to the montratec acquisition offset by $989,000 due to lower net business realignment costs during the three months ended December 31, 2023. Foreign currency translation had a $450,000 unfavorable impact on selling expenses in the three months ended December 31, 2023.

General and administrative expenses were $26,255,000 and $25,143,000, or 10.3% and 10.9% of net sales, in the fiscal 2024 and 2023 third quarters, respectively. General and administrative expenses increased by $1,137,000 from the montratec acquisition, $930,000 of net business realignment costs, $195,000 of net headquarters relocation costs offset by $1,230,000 final adjustment in the prior year for the Garvey acquisition contingent consideration, and $225,000 of lower net acquisition and deal costs. Foreign currency translation had a $285,000 unfavorable impact on general and administrative expenses in the three months ended December 31, 2023.

Research and development expenses were $6,692,000 and $4,839,000, or 2.6% and 2.1% of net sales, in the fiscal 2024 and 2023 third quarters, respectively. The increase in research and development expenses was due to additional spending to achieve strategic goals related to new product development.

Amortization of intangibles was $7,486,000 and $6,459,000 in the fiscal 2024 and 2023 third quarters, respectively, with the increase related to new intangible assets recorded from the montratec acquisition.

Interest and debt expense was $9,952,000 in the third quarter ended December 31, 2023 compared to $7,303,000 in the third quarter ended December 31, 2022. The increase is related to higher variable interest rates, as well as increased borrowings to finance the montratec acquisition.

Investment income of $758,000 in the third quarter ended December 31, 2023 compared to $574,000 in the third quarter ended December 31, 2022 is related to mark-to-market adjustments on the marketable securities held in the Company’s wholly owned captive insurance subsidiary and the Company's equity method investment in EMC, described in Note 6 of the financial statements.

Foreign currency exchange gains were $1,155,000 and $3,359,000 in the fiscal 2024 and 2023 third quarters, respectively. This favorable change was primarily due to the strengthening of the Euro in comparison to the U.S. Dollar during the quarter.

Other expense was $5,234,000 in the third quarter ended December 31, 2023 compared to $79,000 in the third quarter ended December 31, 2022. As described in Note 10, the Company recorded a settlement charge in the amount of $4,599,000 associated with the process to terminate one of the Company's U.S. pension plans.

Income tax expense as a percentage of income from continuing operations before income tax expense was 29% and 28% in the third quarters ended December 31, 2023 and December 31, 2022, respectively. Typically, these percentages vary from the U.S. statutory rate of 21% primarily due to varying statutory tax rates at the Company's foreign subsidiaries, and the jurisdictional mix of income for these subsidiaries.

Nine Months Ended December 31, 2023 and December 31, 2022

Net sales in the nine months ended December 31, 2023 were $748,036,000, up $65,639,000 or 9.6% from the nine months ended December 31, 2022 net sales of $682,397,000. Net sales were positively impacted by $28,092,000 due to price increases and $27,728,000 of revenue from the montratec acquisition offset by $240,000 of unfavorable sales volume. Foreign currency translation favorably impacted sales by $10,059,000 for the nine months ended December 31, 2023.

Gross profit in the nine months ended December 31, 2023 was $280,523,000, an increase of $29,642,000 or 11.8% from the nine months ended December 31, 2022 gross profit of $250,881,000. Gross profit margin was 37.5% in the nine months ended December 31, 2023 compared to 36.8% in the nine months ended December 31, 2022. The increase in gross profit was due to $15,777,000 of price increases net of manufacturing costs changes including inflation, $13,028,000 as a result of the acquisition of montratec and a $904,000 favorable product liability reserve adjustments. These gross profit increases were offset by $2,714,000 of unfavorable sales mix and $781,000 in current year business realignment costs. The translation of foreign currencies had a $3,428,000 favorable impact on gross profit in the nine months ended December 31, 2023.

Selling expenses were $78,400,000 and $77,197,000, or 10.5% and 11.3% of net sales, in the nine months ended December 31, 2023 and December 31, 2022, respectively. Selling expense increased by $4,597,000 due to the montratec acquisition offset by $2,970,000 due to lower net business realignment costs and $1,461,000 of lower employee related costs during the nine months ended December 31, 2023. Foreign currency translation had a $933,000 unfavorable impact on selling expenses in the nine months ended December 31, 2023.

General and administrative expenses were $79,407,000 and $68,441,000, or 10.6% and 10.0% of net sales, in the nine months ended December 31, 2023 and December 31, 2022, respectively. General and administrative expenses increased by $2,765,000 of net acquisition deal related costs, $2,607,000 from the montratec acquisition, $1,852,000 of higher stock compensation costs, $1,569,000 of net headquarters relocation costs, and $283,000 of net business realignment costs. The remaining increase of $2,482,000 is largely due to higher incentive compensation costs, lease costs and medical costs. These increases were offset by a $1,230,000 final adjustment in the prior year for the Garvey acquisition contingent consideration. Foreign currency translation had a $637,000 unfavorable impact on general and administrative expenses in the nine months ended December 31, 2023.

Research and development expenses were $19,134,000 and $15,429,000, or 2.6% and 2.3% of net sales, in the nine months ended December 31, 2023 and December 31, 2022, respectively. The increase in research and development expenses was due to additional spending to achieve strategic goals related to new product development.

Amortization of intangibles was $21,871,000 and $19,442,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively, with the increase related to new intangible assets recorded from the montratec acquisition and foreign currency.

Interest and debt expense was $28,788,000 compared to $20,274,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively. The increase is related to higher variable interest rates, as well as increased borrowings to finance the montratec acquisition.

Investment income of $1,212,000 compared to investment loss of $168,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively, is related to mark-to-market adjustments on the marketable securities held in the Company’s wholly owned captive insurance subsidiary and the Company's equity method investment in EMC, described in Note 6 of the financial statements.

Foreign currency exchange loss was $1,074,000 compared to a foreign currency gain $1,152,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively. This unfavorable change was due to the strengthening of the U.S. Dollar in comparison to the Euro and other currencies where our businesses operate during the first two quarters of fiscal 2024. The Company has begun to recover some of the prior quarters losses in the third quarter as the Euro is strengthening against the U.S. dollar.

Other expense was $5,840,000 in the nine months ended December 31, 2023 compared to other income of $1,999,000 in the nine months ended December 31, 2022. As described in Note 10, the Company recorded a settlement charge in the amount of $4,599,000 associated with the process to terminate one of the Company's U.S. pension plans. As described in Note 13, in fiscal 2023, the Company received a tax indemnification reimbursement received from STAHL's former owners in accordance with the share purchase agreement.

Income tax expense as a percentage of income from continuing operations before income tax expense was 26% and 35% in the nine months ended December 31, 2023 and December 31, 2022, respectively. Typically, these percentages vary from the U.S. statutory rate of 21% primarily due to varying statutory tax rates at the Company's foreign subsidiaries, and the jurisdictional mix of income for these subsidiaries.

The Company estimates that the effective tax rate related to continuing operations will be approximately 24% to 26% for fiscal 2024.

Liquidity and Capital Resources

Cash, cash equivalents, and restricted cash totaled $103,195,000 at December 31, 2023, a decrease of $30,231,000 from the March 31, 2023 balance of $133,426,000.

Cash flow from operating activities

Net cash provided by operating activities was $28,591,000 for the nine months ended December 31, 2023 compared to $16,902,000 for the nine months ended December 31, 2022. Net income of $34,816,000 along with non-cash adjustments to net income of $49,663,000 contributed to cash provided by operations. The non-cash adjustments included $34,052,000 of depreciation and amortization, $8,473,000 of stock-based compensation, $7,080,000 of non-cash lease expense and $4,599,000 of a non-cash pension settlement charge offset by $6,495,000 of deferred income taxes and related valuation allowance. The non-cash pension settlement charge relates to certain employees electing lump sum payments associated with the termination of one of the Company's U.S. pension plans (refer to Note 10 for further details). Changes in working capital reduced cash from operations by $44,195,000 as a result of an increase of $17,764,000 in inventories, an increase in trade accounts receivable $14,911,000, a decrease in accrued expenses of $7,236,000, an increase in prepaid expenses of $2,897,000, and a decrease of $1,387,000 in trade payables. The increase in inventories relates to purchases required for expected future customer demand. Cash used for operations also included a decrease of $10,834,000 in other non-current liabilities primarily due to lease payments for the nine months ended December 31, 2023.

Cash flow from investing activities

Net cash used for investing activities was $125,965,000 for the nine months ended December 31, 2023 compared to $10,912,000 for the nine months ended December 31, 2022. The most significant use of cash in the year was $108,145,000 of cash used for purchase of montratec on May 31, 2023. Additionally, the Company used $16,334,000 for capital expenditures for the nine months ended December 31, 2023 .

Cash flow from financing activities

Net cash provided by financing activities was $67,771,000 for the nine months ended December 31, 2023 and net cash used for financing activities was $37,639,000 for the nine months ended December 31, 2022. The most significant source of cash was $120,000,000 in gross proceeds from the issuance of long-term debt, which was used to fund the montratec acquisition. This was offset by $40,447,000 in debt repayments, $6,027,000 in dividend payments and $2,859,000 in fees paid to secure the new debt borrowings. Associated cash flows from hedging activities are classified as financing activities in the Statement of Cash Flows which resulted in a net cash outflow of $1,215,000 during the nine months ended December 31, 2023.

We believe that our cash on hand, cash flows, and borrowing capacity under our Amended and Restated Credit Agreement will be sufficient to fund our ongoing operations and debt obligations, and capital expenditures for at least the next twelve months. This belief is dependent upon successful execution of our current business plan and effective working capital utilization. No material restrictions exist in accessing cash held by our non-U.S. subsidiaries. We expect to meet our funding needs with cash provided by our U.S. operations, as well as by repatriating non-U.S. cash. We do not expect to incur significant incremental

U.S. taxes as we repatriate funds. As of December 31, 2023, $58,277,000 of cash and cash equivalents were held by foreign subsidiaries.

Refer to Note 9 for further discussion of the Company's long-term debt and financing costs.

Capital Expenditures

In addition to keeping our current equipment and plants properly maintained, we are committed to replacing, enhancing and upgrading our property, plant and equipment to support new product development, improve productivity and customer responsiveness, reduce production costs, increase flexibility to respond effectively to market fluctuations and changes, meet environmental requirements, enhance safety and promote ergonomically correct work stations. Consolidated capital expenditures for the nine months ended December 31, 2023 and December 31, 2022 were $16,334,000 and $9,511,000, respectively. We expect capital expenditure spending in fiscal 2024 to range from $30,000,000 to $35,000,000.

Inflation and Other Market Conditions

Our costs are affected by inflation in the U.S. economy and, to a lesser extent, in non-U.S. economies including those of Europe, Canada, Mexico, South America, and Asia-Pacific. We do not believe that general inflation has had a material effect on our results of operations over the periods presented despite rising inflation due to our ability to pass on rising costs through price increases. We are currently experiencing higher raw material, freight, and logistics costs than we have seen in recent years, which we have been able to recover with pricing actions. In the future, we may not be able to pass on these cost increases to our customers.

Goodwill Impairment Testing

We test goodwill for impairment at least annually and more frequently whenever events occur or circumstances change that indicate there may be impairment. These events or circumstances could include a significant long-term adverse change in the business climate, poor indicators of operating performance, or a sale or disposition of a significant portion of a reporting unit.

We test goodwill at the reporting unit level, which is one level below our operating segment. We identify our reporting units by assessing whether the components of our operating segment constitute businesses for which discrete financial information is available and segment management regularly reviews the operating results of those components. We also aggregate components that have similar economic characteristics into single reporting units (for example, similar products and / or services, similar long-term financial results, product processes, classes of customers, etc.). We have three reporting units: the Duff Norton reporting unit, the Rest of Products reporting unit, and the Precision Conveyance reporting unit, which have goodwill totaling $9,699,000, $308,693,000, and $410,035,000, respectively, as of December 31, 2023.

We currently do not believe that it is more likely than not that the fair value of each of our reporting units is less than its applicable carrying value. Additionally, we currently do not believe that we have any significant impairment indicators or that any of our reporting units with goodwill are at risk of failing Step One of the goodwill impairment test. However, if the projected long-term revenue growth rates, profit margins, or terminal growth rates are significantly lower, and/or the estimated weighted-average cost of capital is considerably higher, future testing may indicate impairment of one or more of the Company’s reporting units and, as a result, the related goodwill may be impaired.

Refer to our 2023 10-K for additional information regarding our annual goodwill impairment process.

Seasonality and Quarterly Results

Quarterly results may be materially affected by the timing of large customer orders, periods of high vacation and holiday concentrations, legal settlements, gains or losses in our portfolio of marketable securities, restructuring charges, favorable or unfavorable foreign currency translation, divestitures and acquisitions. Therefore, the operating results for any particular fiscal quarter are not necessarily indicative of results for any subsequent fiscal quarter or for the full fiscal year.

Effects of New Accounting Pronouncements

Information regarding the effects of new accounting pronouncements is included in Note 16 to the accompanying consolidated financial statements included in this Quarterly Report on Form 10-Q.

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are subject to the safe harbor created thereby under the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical or current fact, included in this Form 10-Q are forward-looking statements. Forward-looking statements reflect our current expectations and projections relating to our financial condition, results of operations, plans, objectives, future performance and business. These statements can be identified by the use of forward-looking words, such as “anticipate,” “estimate,” “expect,” “project,” “plan,” “intend,” “believe,” “may,” “will,” “should,” “can have,” “future,” “likely” and other words and terms of similar meaning (including their negative counterparts or other various or comparable terminology). For example, all statements we make relating to our plans and objectives for future operations, growth or initiatives, strategies, pending acquisitions, our expected amount of capital expenditures for fiscal 2024, our expected effective tax rate for fiscal 2024, or the expected outcome or impact of pending or threatened litigation are forward-looking statements. All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected, including:

•the cyclical nature of our business and general macroeconomic conditions;

•increased competition with respect to our business, including with respect to our material handling and precision conveyance products;

•our ability to successfully integrate our acquisitions;

•price fluctuations and trade tariffs on steel, aluminum, and other raw materials purchased to manufacture our products and our ability to pass on price increases to our customers;

•the scarcity or unavailability of the raw materials and critical components we use to manufacture our products and the impact of such scarcity or unavailability on our ability to operate our business;

•our ability to successfully manage our backlog;

•our ability to maintain relationships with the independent distributors we use to sell our products;

•our ability to continue to attract, develop, engage, and retain qualified employees;

•changing interest rates;

•our ability to manage our indebtedness, including compliance with debt covenant restrictions in our Term Loan B, AR Securitization Facility and our New Revolving Credit Facility (each as defined herein);

•our ability to manage the risks of conducting operations outside of the United States, including currency fluctuations, trade barriers, labor unrest, geopolitical conflicts, more stringent labor regulation, tariffs, political and economic instability and governmental expropriation;

•potential product liability, as our products involve risks of personal injury and property damage;

•compliance with federal, state and local environmental protection laws, including regulatory measures meant to address climate change, which may be burdensome and lower our margins;

•our ability to adequately protect our intellectual property and refrain from infringing on the intellectual property of others;

•our ability to adequately manage and rely on our subcontractors and suppliers;

•our ability to adequately protect our information technology systems from cyberattacks or other interruptions;

•our ability to comply with the U.S. Foreign Corrupt Practices Act and other anti-corruption laws; and

•our ability to retain key members of our management team.

While we believe that the forward-looking statements in this Form 10-Q are reasonable, we caution that it is very difficult to predict the effect of known factors, and, it is impossible for us to anticipate all factors that could affect our actual results. Important factors that could cause actual results to differ materially from our expectations are disclosed under the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Form 10-Q. All written and oral forward-looking statements attributable to us, or persons acting on our behalf, are expressly qualified in their entirety by the cautionary statements as well as other cautionary statements that are made from time to time in our other filings with the SEC and public communications. You should evaluate all forward-looking statements made in this Form 10-Q in the context of these risks and uncertainties.

We caution you that the important factors referenced above may not contain all of the factors that are important to you. In addition, we cannot assure you that we will realize the results or developments we expect or anticipate or, even if substantially realized, that they will result in the outcomes or affect us or our operations in the way we expect. The forward-looking statements included in this Form 10-Q are made only as of the date hereof and are based on our current expectations. We undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise except to the extent required by applicable law.

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have been no material changes in the market risks as previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023.

Item 4. Controls and Procedures.

As of December 31, 2023, an evaluation was performed under the supervision and with the participation of the Company’s management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. These disclosure controls and procedures have been designed to provide reasonable assurance that information required to be disclosed in reports filed or submitted under the Exchange Act is made known to them on a timely basis, and that such information is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Based on that evaluation, the Company’s management, including our Chief Executive Officer and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective as of December 31, 2023.

There have been no other changes in the Company’s internal control over financial reporting during the most recent quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Part II. Other Information

Item 1. Legal Proceedings.

There have been no material developments from the legal proceedings as previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023 and the notes to the consolidated financial statements thereto.

Item 1A. Risk Factors.

There have been no material changes from the risk factors as previously disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2023.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The following table presents information with respect to purchase of common stock of the Company made during the three months ended December 31, 2023 by the Company:

Issuer Purchases of Equity Securities


Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Program	Approximate Dollar Value of Shares that May Yet be Purchased under the thousands Program (in thousands)1
October 1 - 31, 2023	—	$	—	—
November 1 - 30, 2023	—	$	—	—
December 1 - 31, 2023	—	$	—	—
Total	—	$	—	—	19,000

1The Company publicly announced on March 26, 2019 that its Board of Directors approved a share repurchase authorization for up to $20 million of shares of common stock of Columbus McKinnon Corporation, with no expiration. As of December 31, 2023, approximately $19 million remains available to repurchase shares of common stock under the current share repurchase authorization plan. There were no repurchases made in the quarter ended December 31, 2023.

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable

Item 5. Other Information.

During the three months ended December 31, 2023, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

Item 6. Exhibits.


Exhibit 31.1*						Certification of principal executive officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934; as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 31.2*						Certification of prinicipal financial officer pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934; as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

Exhibit 32*						Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Exhibit 101*						The financial statements from the Company’s Quarterly Report on Form 10-Q for the nine months ended December 31, 2023 formatted in iXBRL.

101.INS*						XBRL Instance Document

101.SCH*						XBRL Taxonomy Extension Schema Document

101.CAL*						XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF*						XBRL Taxonomy Extension Definition Linkbase Document

101.LAB*						XBRL Taxonomy Extension Label Linkbase Document

101.PRE*						XBRL Taxonomy Extension Presentation Linkbase Document

Exhibit 104*						Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)

* Filed herewith

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


		COLUMBUS McKINNON CORPORATION
		(Registrant)

Date:	January 31, 2024	/S/ GREGORY P. RUSTOWICZ
		Gregory P. Rustowicz
		Executive Vice President Finance and Chief Financial Officer
		(Principal Financial Officer and Principal Accounting Officer)

Exhibit 31.1

CERTIFICATION

I, David J. Wilson, Chief Executive Officer, certify that:

1.I have reviewed this report on Form 10-Q of Columbus McKinnon Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a.designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a.all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:			January 31, 2024


/S/ DAVID J. WILSON
David J. Wilson
Chief Executive Officer
(Principal Executive Officer)

Exhibit 31.2

CERTIFICATION

I, Gregory P. Rustowicz, Chief Financial Officer, certify that:

1.I have reviewed this report on Form 10-Q of Columbus McKinnon Corporation;

b.any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date:			January 31, 2024


/S/ GREGORY P. RUSTOWICZ
Gregory P. Rustowicz
Executive Vice President Finance and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)

Exhibit 32

CERTIFICATION

Each of the undersigned hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Columbus McKinnon Corporation (the "Company") on Form 10-Q for the quarterly period ended September 30, 2023, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.


Date:			January 31, 2024


/S/ DAVID J. WILSON
David J. Wilson
Chief Executive Officer
(Principal Executive Officer)


/S/ GREGORY P. RUSTOWICZ
Gregory P. Rustowicz
Executive Vice President Finance and Chief Financial Officer
(Principal Financial Officer and Principal Accounting Officer)

Cover - shares	9 Months Ended
Cover - shares	Dec. 31, 2023	Jan. 29, 2024
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Dec. 31, 2023
Document Transition Report	false
Entity File Number	001-34362
Entity Registrant Name	Columbus McKinnon Corporation
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	16-0547600
Entity Address, Address Line One	13320 Ballantyne Corporate Place, Suite D
Entity Address, City or Town	Charlotte
Entity Address, State or Province	NC
Entity Address, Postal Zip Code	28277
City Area Code	(716)
Local Phone Number	689-5400
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	CMCO
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		28,755,978
Amendment Flag	false
Entity Central Index Key	0001005229
Current Fiscal Year End Date	--03-31
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Current assets:
Cash and cash equivalents	$ 102,945	$ 133,176
Trade accounts receivable, less allowance for doubtful accounts ($3,955 and $3,620, respectively)	173,411	151,451
Inventories	204,396	179,359
Prepaid expenses and other	35,660	32,254
Total current assets	516,412	496,240
Property, plant, and equipment, net	102,729	94,360
Goodwill	728,427	644,629
Other intangibles, net	396,317	362,537
Marketable securities	12,388	10,368
Deferred taxes on income	1,990	2,035
Other assets	99,047	88,286
Total assets	1,857,310	1,698,455
Current liabilities:
Trade accounts payable	76,151	76,736
Accrued liabilities	142,518	124,317
Current portion of long-term debt and finance lease obligations	50,652	40,604
Total current liabilities	269,321	241,657
Term loan, AR securitization facility and finance lease obligations	499,388	430,988
Other non current liabilities	210,164	192,013
Total liabilities	978,873	864,658
Shareholders' equity:
Voting common stock; 50,000,000 shares authorized; 28,755,651 and 28,611,721 shares issued and outstanding	288	286
Treasury stock	(1,001)	(1,001)
Additional paid in capital	522,587	515,797
Retained earnings	387,550	356,758
Accumulated other comprehensive loss	(30,987)	(38,043)
Total shareholders' equity	878,437	833,797
Total liabilities and shareholders' equity	$ 1,857,310	$ 1,698,455

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 3,955	$ 3,620
Common stock, authorized (in shares)	50,000,000	50,000,000
Common stock, issued (in shares)	28,755,651	28,611,721
Common stock, outstanding (in shares)	28,755,651	28,611,721

Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net sales	$ 254,143	$ 230,370	$ 748,036	$ 682,397
Cost of products sold	160,246	148,326	467,513	431,516
Gross profit	93,897	82,044	280,523	250,881
Selling expenses	26,552	25,424	78,400	77,197
General and administrative expenses	26,255	25,143	79,407	68,441
Research and development expenses	6,692	4,839	19,134	15,429
Amortization of intangibles	7,486	6,459	21,871	19,442
Operating expenses	66,985	61,865	198,812	180,509
Income from operations	26,912	20,179	81,711	70,372
Interest and debt expense	9,952	7,303	28,788	20,274
Investment (income) loss	(758)	(574)	(1,212)	168
Foreign currency exchange (gain) loss	(1,155)	(3,359)	1,074	(1,152)
Other (income) expense, net	5,234	79	5,840	(1,999)
Income (loss) before income tax expense (benefit)	13,639	16,730	47,221	53,081
Income tax expense (benefit)	3,911	4,701	12,405	18,547
Net income (loss)	$ 9,728	$ 12,029	$ 34,816	$ 34,534
Average basic shares outstanding (in shares)	28,744	28,626	28,711	28,597
Average diluted shares outstanding (in shares)	28,991	28,778	28,979	28,767
Basic income (loss) per share (in dollars per share)	$ 0.34	$ 0.42	$ 1.21	$ 1.21
Diluted income (loss) per share (in dollars per share)	0.34	0.42	1.20	1.20
Dividends declared per common share (in dollars per share)	$ 0.07	$ 0.07	$ 0.14	$ 0.14

Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ 9,728	$ 12,029	$ 34,816	$ 34,534
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments	13,339	12,272	6,557	(7,210)
Change in derivatives qualifying as hedges, net of taxes of $1,350, $(595), $1,260 ,$(2,833)	(4,206)	1,962	(3,930)	9,337
Change in pension liability and postretirement obligation, net of taxes of $(1,511), $73, $(1,489), $(26)	4,595	(230)	4,429	82
Total other comprehensive income (loss)	13,728	14,004	7,056	2,209
Comprehensive income (loss)	$ 23,456	$ 26,033	$ 41,872	$ 36,743

Condensed Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income [Abstract]
Change in derivatives qualifying as hedges, tax expense (benefit)	$ 1,350	$ 86	$ (176)	$ (595)	$ (1,509)	$ (812)	$ 1,260	$ (2,833)
Change in pension liability and postretirement obligation, tax expense (benefit)	$ (1,511)	$ 27	$ (5)	$ 73	$ (56)	$ (49)	$ (1,489)	$ (26)

Condensed Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Directors	Common Stock	Treasury Stock	Additional Paid-in Capital	Additional Paid-in Capital Directors	Retained Earnings	Accumulated Other Comprehensive Loss
Beginning balance at Mar. 31, 2022	$ 772,803		$ 285	$ 0	$ 506,074		$ 316,343	$ (49,899)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	8,391						8,391
Change in foreign currency translation adjustment	(8,701)							(8,701)
Change in derivative qualifying as hedges, net of tax	2,689							2,689
Change in pension liability and postretirement obligations, net of tax	146							146
Stock compensation expense	751				751
Stock options exercised	415				415
Restricted stock units released	(1,313)		1		(1,314)
Ending balance at Jun. 30, 2022	775,181		286	0	505,926		324,734	(55,765)
Beginning balance at Mar. 31, 2022	772,803		285	0	506,074		316,343	(49,899)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	34,534
Change in foreign currency translation adjustment	(7,210)
Change in derivative qualifying as hedges, net of tax	9,337
Change in pension liability and postretirement obligations, net of tax	82
Ending balance at Dec. 31, 2022	810,881		286	(1,001)	512,418		346,868	(47,690)
Beginning balance at Jun. 30, 2022	775,181		286	0	505,926		324,734	(55,765)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	14,114						14,114
Dividends declared	(2,004)						(2,004)
Change in foreign currency translation adjustment	(10,781)							(10,781)
Change in derivative qualifying as hedges, net of tax	4,686							4,686
Change in pension liability and postretirement obligations, net of tax	166							166
Stock compensation expense	2,341	$ 537			2,341	$ 537
Stock options exercised	206				206
Restricted stock units released	(62)				(62)
Ending balance at Sep. 30, 2022	784,384		286	0	508,948		336,844	(61,694)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	12,029						12,029
Dividends declared	(2,005)						(2,005)
Change in foreign currency translation adjustment	12,272							12,272
Change in derivative qualifying as hedges, net of tax	1,962							1,962
Change in pension liability and postretirement obligations, net of tax	(230)							(230)
Stock compensation expense	3,094	316			3,094	316
Stock options exercised	83				83
Treasury stock purchase	(1,001)			(1,001)
Restricted stock units released	(23)				(23)
Ending balance at Dec. 31, 2022	810,881		286	(1,001)	512,418		346,868	(47,690)
Beginning balance at Mar. 31, 2023	833,797		286	(1,001)	515,797		356,758	(38,043)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	9,275						9,275
Change in foreign currency translation adjustment	2,901							2,901
Change in derivative qualifying as hedges, net of tax	541							541
Change in pension liability and postretirement obligations, net of tax	42							42
Stock compensation expense	1,981				1,981
Stock options exercised	225				225
Restricted stock units released	(1,805)		1		(1,806)
Ending balance at Jun. 30, 2023	846,957		287	(1,001)	516,197		366,033	(34,559)
Beginning balance at Mar. 31, 2023	833,797		286	(1,001)	515,797		356,758	(38,043)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	34,816
Change in foreign currency translation adjustment	6,557
Change in derivative qualifying as hedges, net of tax	(3,930)
Change in pension liability and postretirement obligations, net of tax	4,429
Ending balance at Dec. 31, 2023	878,437		288	(1,001)	522,587		387,550	(30,987)
Beginning balance at Jun. 30, 2023	846,957		287	(1,001)	516,197		366,033	(34,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	15,813						15,813
Dividends declared	(2,012)						(2,012)
Change in foreign currency translation adjustment	(9,683)							(9,683)
Change in derivative qualifying as hedges, net of tax	(265)							(265)
Change in pension liability and postretirement obligations, net of tax	(208)							(208)
Stock compensation expense	2,696	587			2,696	587
Stock options exercised	265				265
Restricted stock units released	(152)				(152)
Ending balance at Sep. 30, 2023	853,998		287	(1,001)	519,593		379,834	(44,715)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	9,728
Dividends declared	(2,012)						(2,012)
Change in foreign currency translation adjustment	13,339							13,339
Change in derivative qualifying as hedges, net of tax	(4,206)							(4,206)
Change in pension liability and postretirement obligations, net of tax	4,595							4,595
Stock compensation expense	2,916	$ 293			2,916	$ 293
Stock options exercised	66				66
Restricted stock units released	(280)		1		(281)
Ending balance at Dec. 31, 2023	$ 878,437		$ 288	$ (1,001)	$ 522,587		$ 387,550	$ (30,987)

Condensed Consolidated Statements of Shareholders' Equity (Parenthetical) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Statement of Stockholders' Equity [Abstract]
Common stock, par value (in USD per share)	$ 0.01			$ 0.01			$ 0.01	$ 0.01
Change in derivatives qualifying as hedges, tax expense (benefit)	$ 1,350	$ 86	$ (176)	$ (595)	$ (1,509)	$ (812)	$ 1,260	$ (2,833)
Change in pension liability and postretirement obligation, tax expense (benefit)	$ (1,511)	$ 27	$ (5)	$ 73	$ (56)	$ (49)	$ (1,489)	$ (26)
Stock options exercised (in shares)	2,900	9,556	8,485	3,258	9,531	18,907
Treasury stock purchase (in shares)				31,085
Restricted stock units released, net of shares withheld for minimum statutory tax obligation (in shares)	15,840	19,653	87,496	6,798	31,313	52,276

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
OPERATING ACTIVITIES:
Net income (loss)	$ 34,816	$ 34,534
Adjustments to reconcile net income (loss) to net cash provided by (used for) operating activities:
Depreciation and amortization	34,052	31,380
Deferred income taxes and related valuation allowance	(6,495)	(783)
Net loss (gain) on sale of real estate, investments and other	(967)	347
Non-cash pension settlement (See Note 10)	4,599	0
Stock-based compensation	8,473	7,039
Amortization of deferred financing costs	1,728	1,291
Loss (gain) on hedging instruments	1,193	(598)
Gain on sale of building	0	(232)
Loss on retirement of fixed asset	0	175
Non-cash lease expense	7,080	5,814
Changes in operating assets and liabilities, net of effects of business acquisitions:
Trade accounts receivable	(14,911)	(1,401)
Inventories	(17,764)	(31,701)
Prepaid expenses and other	(2,897)	4,905
Other assets	(859)	(232)
Trade accounts payable	(1,387)	(18,756)
Accrued liabilities	(7,236)	(7,498)
Non-current liabilities	(10,834)	(7,382)
Net cash provided by (used for) operating activities	28,591	16,902
INVESTING ACTIVITIES:
Proceeds from sales of marketable securities	1,101	2,650
Purchases of marketable securities	(2,731)	(3,121)
Capital expenditures	(16,334)	(9,511)
Proceeds from sale of building, net of transaction costs	0	373
Dividend received from equity method investment	144	313
Purchase of businesses, net of cash acquired (See Note 2)	(108,145)	(1,616)
Net cash provided by (used for) investing activities	(125,965)	(10,912)
FINANCING ACTIVITIES:
Proceeds from the issuance of common stock	556	704
Purchases of treasury stock	0	(1,001)
Repayment of debt	(40,447)	(30,402)
Proceeds from issuance of long-term debt	120,000	0
Fees paid for borrowings on long-term debt	(2,859)	0
Cash inflows from hedging activities	18,088	18,422
Cash outflows from hedging activities	(19,303)	(17,958)
Payment of dividends	(6,027)	(6,006)
Other	(2,237)	(1,398)
Net cash provided by (used for) financing activities	67,771	(37,639)
Effect of exchange rate changes on cash	(628)	(2,221)
Net change in cash and cash equivalents	(30,231)	(33,870)
Cash, cash equivalents, and restricted cash at beginning of year	133,426	115,640
Cash, cash equivalents, and restricted cash at end of period	103,195	81,770
Supplementary cash flow data:
Interest paid	25,332	18,883
Income taxes paid, net of refunds	21,561	18,486
Property, plant and equipment purchases included in trade accounts payable	135	199
Restricted cash presented in Other assets	$ 250	$ 250

Description of Business	9 Months Ended
Description of Business	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business	Description of Business The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the financial position of Columbus McKinnon Corporation ("the Company") at December 31, 2023, the results of its operations for the three and nine months ended December 31, 2023 and December 31, 2022, and cash flows for the nine months ended December 31, 2023 and December 31, 2022, have been included. Results for the period ended December 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2024. The balance sheet at March 31, 2023 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in the Columbus McKinnon Corporation Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “2023 10-K”). The Company is a leading worldwide designer, manufacturer, and marketer of intelligent motion solutions that efficiently and ergonomically move, lift, position, and secure materials. Key products include hoists, crane components, precision conveyor systems, accumulation tables, rigging tools, light rail workstations, and digital power and motion control systems. The Company is focused on commercial and industrial applications that require the safety and quality provided by its superior design and engineering know-how. The Company’s products are sold globally, principally to third party distributors and crane builders through diverse distribution channels, and to a lesser extent directly to end-users and integrators. During the nine months ended December 31, 2023, sales to customers in the United States were approximately 56% of total net sales.

Acquisitions & Disposals

9 Months Ended

Dec. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Acquisitions & Disposals

amortization was estimated at 14 years at the time of acquisition. Of the $78,943,000 goodwill recorded from the acquisition, $7,531,000 is deductible for tax purposes.

The preliminary assignment of purchase consideration to the assets acquired and liabilities assumed is as follows (in thousands):


Cash	$	7,576
Working capital	4,896
Property, plant, and equipment, net	2,157
Intangible assets	52,581
Contingent liability (see above)	(18,355)
Other assets	5,704
Other non current liabilities	(17,781)
Goodwill	78,943
Total	$	115,721

Revenue & Receivables

9 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Revenue & Receivables

Revenue Recognition:

Performance obligations

For additional information on the Company’s revenue recognition policy refer to the consolidated financial statements included in the 2023 10-K.

Reconciliation of contract balances

The following table illustrates the balance and related activity for customer advances in the nine months ended December 31, 2023 and December 31, 2022 (in thousands):


Customer advances (contract liabilities)	December 31, 2023		December 31, 2022
March 31, beginning balance	$	27,003	$	22,453
Additional customer advances received	69,188		56,902
Revenue recognized from customer advances included in beginning of period	(27,003)		(22,453)
Other revenue recognized from customer advances	(47,055)		(34,302)
Customer advances recorded from acquisitions	3,866		—
Other (1)	284		(418)
December 31, ending balance	$	26,283	$	22,182

(1) Other includes the impact of foreign currency translation

Remaining Performance Obligations

Disaggregated revenue

The following table illustrates the disaggregation of revenue by product grouping for the three and nine months ended December 31, 2023 and December 31, 2022 (in thousands):


	Three Months Ended				Nine Months Ended
Net Sales by Product Grouping	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
Industrial Products	$	83,033	$	77,423	$	253,925	$	240,366
Crane Solutions	103,775		97,541		303,746		266,959
Engineered Products	22,710		21,535		70,895		61,309
Precision Conveyor Products	44,588		33,837		119,379		113,646
All other	37		34		91		117
Total	$	254,143	$	230,370	$	748,036	$	682,397

Practical expedients

Accounts Receivable:


Allowance for doubtful accounts	December 31, 2023		December 31, 2022
March 31, beginning balance	$	3,620	$	5,717
Bad debt expense	2,727		726
Less uncollectible accounts written off, net of recoveries	(2,490)		(996)
Allowance recorded from acquisitions	64		—
Other (1)	34		(134)
December 31, ending balance	$	3,955	$	5,313

(1) Other includes the impact of foreign currency translation

Fair Value Measurements

9 Months Ended

Dec. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements

Level 2 - Valuations based on quoted prices in markets that are not active or for which all significant inputs are observable, either directly or indirectly, involving some degree of judgment.

The following table provides information regarding financial assets and liabilities measured or disclosed at fair value (in thousands):


	Fair value measurements at reporting date using
	December 31,		Quoted prices in active markets for identical assets		Significant other observable inputs		Significant unobservable inputs
Description	2023		(Level 1)		(Level 2)		(Level 3)
Assets/(Liabilities) measured at fair value:
Marketable securities	$	12,388	$	12,388	$	—	$	—
Annuity contract	1,409		—		1,409		—

Derivative Assets (Liabilities):
Foreign exchange contracts	(100)		—		(100)		—
Interest rate swap	6,198		—		6,198		—
Cross currency swap	(4,506)		—		(4,506)		—


Disclosed at fair value:
Term Loan B	$	(500,048)	$	—	$	(500,048)	$	—
AR securitization facility	$	(45,000)	$	—	$	(45,000)	$	—


	Fair value measurements at reporting date using
	March 31,		Quoted prices in active markets for identical assets		Significant other observable inputs		Significant unobservable inputs
Description	2023		(Level 1)		(Level 2)		(Level 3)
Assets/(Liabilities) measured at fair value:
Marketable securities	$	10,368	$	10,368	$	—	$	—
Annuity contract	1,612		—		1,612		—
Derivative assets (liabilities):
Foreign exchange contracts	97		—		97		—

Interest rate swap	10,475		—		10,475		—
Cross currency swap	(2,102)		—		(2,102)		—

Disclosed at fair value:
Term loan B	$	(460,825)	$	—	$	(460,825)	$	—

Refer to the 2023 10-K for a full description of the assets and liabilities measured on a non-recurring basis that are included in the Company's March 31, 2023 balance sheet.

Inventories

9 Months Ended

Dec. 31, 2023

Inventory Disclosure [Abstract]

Inventories

Inventories consisted of the following (in thousands):


	December 31, 2023		March 31, 2023
At cost - FIFO basis:
Raw materials	$	167,833	$	142,490
Work-in-process	26,788		26,323
Finished goods	41,449		39,714
Total at cost FIFO basis	236,070		208,527
LIFO cost less than FIFO cost	(31,674)		(29,168)
Net inventories	$	204,396	$	179,359

The acquisition of montratec contributed $4,083,000 to the increase in inventory since March 31, 2023.

Marketable Securities and Other Investments	9 Months Ended
Marketable Securities and Other Investments	Dec. 31, 2023
Marketable Securities [Abstract]
Marketable Securities and Other Investments	Marketable Securities and Other Investments In accordance with ASU 2016-01, “Financial Instruments - Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities,” all equity investments in unconsolidated entities (other than those accounted for using the equity method of accounting) are measured at fair value through earnings. The Company's marketable securities are recorded at their fair value, with unrealized changes in market value realized within Investment (income) loss on the Condensed Consolidated Statements of Operations. The impact on earnings for unrealized gains and losses were gains of $660,000 and $362,000 in the three months ended December 31, 2023 and December 31, 2022, respectively and a gain of $390,000 and a loss of $558,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively. Consistent with prior periods, the estimated fair value is based on quoted market prices at the balance sheet dates. The cost of securities sold is based on the specific identification method. Interest and dividend income are included in Investment (income) loss in the Condensed Consolidated Statements of Operations. Marketable securities are carried as long-term assets since they are held for the settlement of the Company’s general and product liability insurance claims filed through CM Insurance Company, Inc. ("CMIC"), a wholly owned captive insurance subsidiary. The marketable securities are not available for general working capital purposes. Net realized gains related to sales of marketable securities were not material in the three and nine months ended December 31, 2023 and December 31, 2022, respectively. The Company owns a 49% ownership interest in Eastern Morris Cranes Company Limited ("EMC"), a limited liability company organized and existing under the laws and regulations of the Kingdom of Saudi Arabia. The Company's ownership represents an equity investment in a strategic customer of STAHL serving the Kingdom of Saudi Arabia. The investment's carrying value is presented in Other assets in the Condensed Consolidated Balance Sheets in the amount of $3,132,000 and $2,752,000 as of December 31, 2023 and March 31, 2023, respectively, and has been accounted for as an equity method investment. The investment value increased for the Company's ownership percentage of income earned by EMC in the amount of $5,000 and $142,000 in the three months ended December 31, 2023 and December 31, 2022, respectively, and increased by $589,000 and $209,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively, recorded in Investment (income) loss on the Condensed Consolidated Statements of Operations. Further, in the nine months ended December 31, 2023 and December 31, 2022, EMC distributed cash dividends which the Company received 49% of pursuant to its ownership interest. The investment value was decreased for the Company's share of EMC's cash dividend in the amount of $247,000 and $313,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively, as they were determined to be a return of the Company's investment. Dividends are included in investing activities on the Condensed Consolidated Statements of Cash Flows in the amount of $144,000 and $313,000 in the nine months ended December 31, 2023 and December 31, 2022, respectively, as the distribution received exceeded cumulative equity in earnings, under the cumulative earnings approach. The remaining balance of the dividend for the nine months ended December 31, 2023, is included in cash flows from operations. The December 31, 2023 and March 31, 2023 trade accounts receivable balance due from EMC are $8,105,000 and $5,083,000, respectively, and are comprised of amounts due for the sale of goods and services in the ordinary course of business.

Goodwill and Intangible Assets

9 Months Ended

Dec. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

A summary of changes in goodwill during the nine months ended December 31, 2023 is as follows (in thousands):


Balance at April 1, 2023	$	644,629
Acquisition of montratec (Refer to Note 2)	78,943
Currency translation	4,855
Balance at December 31, 2023	728,427

Goodwill is recognized net of accumulated impairment losses of $113,174,000 as of December 31, 2023 and March 31, 2023, respectively.

Identifiable intangible assets acquired in a business combination are amortized over their estimated useful lives. Identifiable intangible assets are summarized as follows (in thousands):


	December 31, 2023						March 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Trademark	$	22,576	$	(7,582)	$	14,994	$	19,478	$	(6,315)	$	13,163
Indefinite lived trademark	46,672		—		46,672		46,338		—		46,338
Customer relationships	359,264		(104,850)		254,414		322,658		(88,685)		233,973
Acquired technology	112,894		(33,342)		79,552		96,291		(27,945)		68,346
Other	3,801		(3,116)		685		3,585		(2,868)		717
Total	$	545,207	$	(148,890)	$	396,317	$	488,350	$	(125,813)	$	362,537

Derivative Instruments

9 Months Ended

Dec. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments

As of December 31, 2023, the Company had no derivatives designated as net investments or fair value hedges in accordance with FASB ASC Topic 815, “Derivatives and Hedging.”

The following is the effect of derivative instruments on the Condensed Consolidated Statements of Operations for the three months ended December 31, 2023 and 2022 (in thousands):

Derivatives Designated as Cash Flow Hedges

Type of Instrument

Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives

Location of Gain or (Loss) Recognized in Income on Derivatives

Amount of Gain or (Loss) Reclassified from AOCL into Income

December 31, 2023

Foreign exchange contracts

(31)

Cost of products sold

(22)

December 31, 2023

Interest rate swaps

(1,958)

Interest expense

2,566

December 31, 2023

Cross currency swaps

(2,921)

Foreign currency exchange (gain) loss

(3,248)

December 31, 2022

Foreign exchange contracts

137

Cost of products sold

(64)

December 31, 2022

Interest rate swap

1,018

Interest expense

1,170

December 31, 2022

Cross currency swaps

(6,004)

Foreign currency exchange (gain) loss

(7,916)

The following is the effect of derivative instruments on the Condensed Consolidated Statements of Operations for the nine months ended December 31, 2023 and 2022 (in thousands):

Derivatives Designated as Cash Flow Hedges

Type of Instrument

Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives

Location of Gain or (Loss) Recognized in Income on Derivatives

Amount of Gain or (Loss) Reclassified from AOCL into Income

December 31, 2023

Foreign exchange contracts

(211)

Cost of products sold

(75)

December 31, 2023

Interest rate swaps

4,131

Interest expense

7,424

December 31, 2023

Cross currency swaps

(1,701)

Foreign currency exchange (gain) loss

(1,200)

December 31, 2022

Foreign exchange contracts

Cost of products sold

(153)

December 31, 2022

Interest rate swap

7,423

Interest expense

488

December 31, 2022

Cross currency swaps

5,623

Foreign currency exchange (gain) loss

3,464

The following is information relative to the Company’s derivative instruments in the Condensed Consolidated Balance Sheets (in thousands):


		Fair Value of Asset (Liability)
Derivatives Designated as Hedging Instruments	Balance Sheet Location	December 31, 2023		March 31, 2023
Foreign exchange contracts	Prepaid expenses and other	$	22	$	—
Foreign exchange contracts	Other Asset	—		136
Foreign exchange contracts	Accrued liabilities	(122)		(39)
Interest rate swap	Prepaid expenses and other	7,501		7,644
Interest rate swap	Other assets	433		3,218
Interest rate swap	Accrued liabilities	—		(387)
Interest rate swap	Other non current liabilities	(1,736)		—
Cross currency swap	Prepaid expenses and other	—		168
Cross currency swap	Accrued liabilities	(284)		—
Cross currency swap	Other non current liabilities	(4,222)		(2,270)

Debt	9 Months Ended
Debt	Dec. 31, 2023
Debt Disclosure [Abstract]
Debt	Debt During fiscal 2024, the Company amended its New Revolving Credit Facility increasing the size of the New Revolving Credit Facility by $75,000,000 to a total of $175,000,000. The Company borrowed against the expanded New Revolving Credit Facility in May of fiscal 2024 to initially fund the montratec acquisition as described in Note 2. The Company subsequently borrowed additional funds in accordance with the Accordion feature under its existing Term Loan B facility to increase the principal amount of the Term Loan B facility by $75,000,000. The Company also borrowed an additional $45,000,000 under a new credit agreement secured by the Company's U.S. accounts receivable balances (the "AR Securitization Facility"). The total U.S. accounts receivable balances which secure the AR Securitization Facility total $72,736,000 as of December 31, 2023. The Company used the proceeds from the $75,000,000 Accordion borrowing and the $45,000,000 AR Securitization Facility to fully repay borrowings on the New Revolving Credit Facility prior to June 30, 2023. The key terms of the new AR Securitization Facility are as follows: •The AR Securitization Facility Agreement provides for revolving loans to be made up to a maximum principal amount of $55,000,000 of which $45,000,000 was drawn as of December 31, 2023. •The AR Securitization Facility borrowings bear interest at a floating rate equal to a one-month secured overnight funding rate (SOFR) plus 10 basis points of credit spread adjustment, plus 110 basis points. •The AR Securitization Facility borrowings are secured by the Company's U.S. accounts receivables totaling $72,736,000 at December 31, 2023. •The AR Securitization Facility Agreement contains customary events of default (referred to as “Amortization Events.”) •Amounts drawn under the AR Securitization Facility may remain outstanding until the maturity date of the AR Securitization Facility on June 19, 2026. Prior to the maturity date, the Company is only required to repay principal to the extent necessary to maintain borrowing base compliance, unless an Amortization Event occurs. As of December 31, 2023, there have been no Amortization Events triggered in the AR Securitization Facility. The Company has both the ability and intent to have the AR Securitization Facility remain outstanding for the next 12-months. As such, the Company has classified the full $45,000,000 outstanding borrowings under the AR Securitization Facility as long-term debt at December 31, 2023. In addition to the above, the Company amended the variable interest component of its Term Loan B and New Revolving Credit Facility to transition from LIBOR to SOFR. The outstanding principal balance of the Term Loan B facility was $497,560,000 as of December 31, 2023, which includes $75,000,000 in principal balance from the Accordion exercised in the first quarter of fiscal 2024 as described above. The Company made $40,000,000 in principal payments on the Term Loan B facility during the nine months ended December 31, 2023 of which $4,585,000 was required. The Company is obligated to make $6,113,000 of principal payments on the Term Loan B facility over the next 12 months plus applicable Excess Cash Flow ("ECF") payments, if required, however, plans to pay down approximately $50,000,000 in principal payments in total during such 12 month period. This amount has been recorded within the current portion of long-term debt on the Company's Condensed Consolidated Balance Sheet with the remaining balance recorded as long-term debt. Refer to the 2023 10-K for further details on the Company's Term Loan B facility. There were no outstanding borrowings and $15,740,000 in outstanding letters of credit issued against the New Revolving Credit Facility as of December 31, 2023. The outstanding letters of credit as of December 31, 2023 consisted of $171,000 in commercial letters of credit and $15,569,000 of standby letters of credit. The gross balance of deferred financing costs on the Term Loan B facility was $7,845,000, which includes $2,414,000 from the Accordion exercises, as of December 31, 2023 and $6,323,000, which includes $892,000 from the Accordion exercise, as of March 31, 2023. The accumulated amortization balances were $2,663,000 and $1,815,000 as of December 31, 2023 and March 31, 2023, respectively. The gross balance of deferred financing costs associated with the AR Securitization Facility was $536,000 with an accumulated amortization balance of $104,000 as of December 31, 2023. The gross balance of deferred financing costs associated with the New Revolving Credit Facility is $4,828,000 as of December 31, 2023 and $4,027,000 as of March 31, 2023, respectively, which are included in Other assets on the Condensed Consolidated Balance Sheet. The $801,000 increase in Fiscal 2024 relates to fees paid to increase the size of the New Revolving Credit Facility to $175,000,000 as described above. The accumulated amortization balances were $2,385,000 and $1,611,000 as of December 31, 2023 and March 31, 2023, respectively. The Company has a finance lease for a manufacturing facility in Hartland, WI under a 23-year lease agreement which terminates in 2035. The outstanding balance on the finance lease obligation is $13,093,000 as of December 31, 2023 of which $652,000 has been recorded within the Current portion of long-term debt and the remaining balance recorded within the Term loan, AR securitization facility and finance lease obligations on the Company's Condensed Consolidated Balance Sheet. See Note 15 for further details. Unsecured and uncommitted lines of credit are available to meet short-term working capital needs for certain of our subsidiaries operating outside of the U.S. The lines of credit are available on an offering basis, meaning that transactions under the line of credit will be on such terms and conditions, including interest rate, maturity, representations, covenants and events of default, as mutually agreed between our subsidiaries and the local bank at the time of each specific transaction. As of December 31, 2023, unsecured credit lines totaled approximately $2,428,000, of which nothing was drawn. In addition, unsecured lines of $13,541,000 were available for bank guarantees issued in the normal course of business of which $10,758,000 was utilized as of December 31, 2023. Refer to the Company’s consolidated financial statements included in its 2023 10-K for further information on its debt arrangements.

Net Periodic Benefit Cost

9 Months Ended

Dec. 31, 2023

Retirement Benefits [Abstract]

Net Periodic Benefit Cost

The following table sets forth the components of net periodic pension cost for the Company’s defined benefit pension plans (in thousands):


	Three Months Ended				Nine Months Ended
	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
Service costs	$	136	$	199	$	389	$	536
Interest cost	3,419		2,848		10,351		8,537
Expected return on plan assets	(2,867)		(2,709)		(8,759)		(8,130)
Net amortization	62		192		266		607
Settlement	$	4,639	$	—	$	4,720	$	—
Net periodic pension (benefit) cost	$	5,389	$	530	$	6,967	$	1,550

The Company currently plans to contribute approximately $6,908,000 to its pension plans in fiscal 2024.

For additional information on the Company’s defined benefit pension and postretirement benefit plans, refer to the consolidated

financial statements included in the 2023 10-K.

Earnings Per Share

9 Months Ended

Dec. 31, 2023

Earnings Per Share [Abstract]

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands):


	Three Months Ended				Nine Months Ended
	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
Numerator for basic and diluted earnings per share:
Net income (loss)	$	9,728	$	12,029	$	34,816	$	34,534

Denominators:
Weighted-average common stock outstanding – denominator for basic EPS	28,744		28,626		28,711		28,597
Effect of dilutive employee stock options and other share-based awards	247		152		268		170
Adjusted weighted-average common stock outstanding and assumed conversions – denominator for diluted EPS	28,991		28,778		28,979		28,767

Refer to the Company’s consolidated financial statements included in its 2023 10-K for further information on its earnings per share and stock plans.

Loss Contingencies

9 Months Ended

Dec. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Loss Contingencies

The following table provides a reconciliation of the beginning and ending balances for accrued general and product liability (in thousands):


	December 31, 2023		March 31, 2023
Accrued general and product liability, beginning of period	$	21,103	$	22,575
Estimated insurance recoveries	(773)		(889)
Add provision for claims	1,251		3,025
Deduct payments for claims	(2,231)		(3,608)
Accrued general and product liability, end of period	$	19,350	$	21,103

Estimated insurance recoveries	(7,496)		(8,272)
Net accrued general and product liability, end of period	$	11,854	$	12,831

Asbestos

Product Liability

Litigation-Other

The Company believes it will be successful and does not expect to incur a liability related to these assessments.

Environmental Matters

Income Taxes	9 Months Ended
Income Taxes	Dec. 31, 2023
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income tax expense (benefit) as a percentage of income (loss) from continuing operations before income tax expense was 29% and 28% in the three months ended December 31, 2023 and December 31, 2022, respectively, and 26% and 35% in the nine months ended December 31, 2023 and December 31, 2022, respectively. Typically these percentages vary from the U.S. statutory rate of 21% primarily due to varying statutory tax rates at the Company's foreign subsidiaries, and the jurisdictional mix of income for these subsidiaries. During the nine months ended December 31, 2022, the rate was unfavorably impacted 5 percentage points due to settlement of income tax assessments related to tax periods prior to the Company’s acquisition of Stahl Cranesystems GmbH (“STAHL"). In accordance with the tax indemnification clause of the share purchase agreement, the Company received full reimbursement from STAHL’s prior owner which was recorded as a gain in Other (income) expense, net on the Condensed Consolidated Statements of Operations during the period. The tax rate for the nine months ended December 31, 2022 also reflects an unfavorable impact of 4 percentage points due to the recording of a U.S. state tax valuation allowance. The valuation allowance primarily relates to changes in the Company’s expectations regarding its ability to more likely than not utilize certain state net operating losses prior to their expiration. The Company estimates that the effective tax rate related to continuing operations will be approximately 24% to 26% for fiscal 2024. Refer to the Company’s consolidated financial statements included in its 2023 10-K for further information on income taxes.

Changes in Accumulated Other Comprehensive Loss

9 Months Ended

Dec. 31, 2023

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Changes in Accumulated Other Comprehensive Loss

Changes in AOCL by component for the three and nine months ended December 31, 2023 are as follows (in thousands):


	Three months ended December 31, 2023
	Retirement Obligations		Foreign Currency		Change in Derivatives Qualifying as Hedges		Total
Beginning balance net of tax	$	(12,966)	$	(39,134)	$	7,385	$	(44,715)
Other comprehensive income (loss) before reclassification	1,094		13,339		(4,910)		9,523
Amounts reclassified from other comprehensive loss	3,501		—		704		4,205
Net current period other comprehensive income (loss)	4,595		13,339		(4,206)		13,728
Ending balance net of tax	$	(8,371)	$	(25,795)	$	3,179	$	(30,987)


	Nine Months Ended December 31, 2023
	Retirement Obligations		Foreign Currency		Change in Derivatives Qualifying as Hedges		Total
Beginning balance net of tax	$	(12,800)	$	(32,352)	$	7,109	$	(38,043)
Other comprehensive income (loss) before reclassification	773		6,557		2,219		9,549
Amounts reclassified from other comprehensive loss	3,656		—		(6,149)		(2,493)
Net current period other comprehensive income (loss)	4,429		6,557		(3,930)		7,056
Ending balance net of tax	$	(8,371)	$	(25,795)	$	3,179	$	(30,987)

Details of amounts reclassified out of AOCL for the three months ended December 31, 2023 are as follows (in thousands):


Details of AOCL Components	Amount reclassified from AOCL		Affected line item on Condensed Consolidated Statement of Operations






Net amortization of prior service cost and pension settlement expense
	$	4,652
	4,652		Total before tax
	(1,151)		Tax (benefit) expense
	$	3,501	Net of tax

Change in derivatives qualifying as hedges
	$	29	Cost of products sold
	(3,389)		Interest expense
	4,290		Foreign currency
	930		Total before tax
	(226)		Tax (benefit) expense
	$	704	Net of tax

Details of amounts reclassified out of AOCL for the nine months ended December 31, 2023 are as follows (in thousands):


Details of AOCL Components	Amount reclassified from AOCL		Affected line item on Condensed Consolidated Statement of Operations






Net amortization of prior service cost and pension settlement expense
	$	4,840
	4,840		Total before tax
	(1,184)		Tax (benefit) expense
	$	3,656	Net of tax

Change in derivatives qualifying as hedges
	$	99	Cost of products sold
	(9,807)		Interest expense
	1,585		Foreign currency
	(8,123)		Total before tax
	1,974		Tax (benefit) expense
	$	(6,149)	Net of tax

These AOCL components are included in the computation of net periodic pension cost. (See Note 10 for additional details.)

Leases

9 Months Ended

Dec. 31, 2023

Leases [Abstract]

Leases

The following table illustrates the lease-related assets and liabilities recorded on the Condensed Consolidated Balance Sheet (in thousands):


	December 31, 2023		March 31, 2023
Operating leases:
Other assets	$	65,424	$	53,551

Accrued liabilities	9,511		7,966
Other non current liabilities	58,763		46,524
Total operating liabilities	$	68,274	$	54,490

Finance lease:
Net property, plant, and equipment	$	11,846	$	12,597

Current portion of long-term debt and finance lease obligation	652		604
Term loan and finance lease obligations	12,441		12,937
Total finance liabilities	$	13,093	$	13,541

Supplemental cash flow information related to leases is as follows (in thousands):


	Nine Months Ended December 31,
	2023		2022
Cash paid for amounts included in the measurement of operating lease liabilities	$	7,771	$	6,678
Cash paid for amounts included in the measurement of finance lease liabilities	$	898	$	872
ROU assets obtained in exchange for new operating lease liabilities	$	17,442	$	8,592

Effects of New Accounting Pronouncements	9 Months Ended
Effects of New Accounting Pronouncements	Dec. 31, 2023
Accounting Standards Update and Change in Accounting Principle [Abstract]
Effects of New Accounting Pronouncements	Effects of New Accounting Pronouncements Topics recently adopted In December 2022, the FASB issued ASU 2022-06, "Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848" from December 31, 2022 to December 31, 2024, which is superseding the date from ASU No. 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." This ASU is elective and is relief to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Optional expedients are provided for contract modification accounting under topics such as debt, leases, and derivatives. The optional amendments are effective for all entities as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through December 31, 2024. The Company modified its interest rate swap contracts during the quarter to transition from LIBOR to SOFR. The adoption of this update did not have a material impact on the Company’s consolidated financial statements. In October 2021, the FASB issued ASU No. 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers." The ASU amends ASC 805 to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination and is intended to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those years, with early adoption permitted. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company adopted this standard effective April 1, 2023 and applied it in the purchase accounting for montratec. The adoption did not have a material impact on the Company's consolidated financial statements. Topics Not Yet Adopted We consider the applicability and impact of all ASUs. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The ASU is intended to provide increased transparency about income tax information through improvements to income tax disclosures related to the rate reconciliation and income taxes paid. The Company is currently assessing the impact this ASU will have on the footnotes of its annual financial statements. The Company plans to adopt this standard in fiscal 2026 when required. ASUs not listed were assessed and determined to be either not applicable, or had or are expected to have an immaterial impact on our financial statements and related disclosures.

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net income (loss)	$ 9,728	$ 15,813	$ 9,275	$ 12,029	$ 14,114	$ 8,391	$ 34,816	$ 34,534

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Description of Business (Policies)	9 Months Ended
Description of Business (Policies)	Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting	The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles ("U.S. GAAP") for interim financial information. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of the financial position of Columbus McKinnon Corporation ("the Company") at December 31, 2023, the results of its operations for the three and nine months ended December 31, 2023 and December 31, 2022, and cash flows for the nine months ended December 31, 2023 and December 31, 2022, have been included. Results for the period ended December 31, 2023 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2024. The balance sheet at March 31, 2023 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by U.S. GAAP for complete financial statements. For further information, refer to the consolidated financial statements and footnotes thereto included in the Columbus McKinnon Corporation Annual Report on Form 10-K for the fiscal year ended March 31, 2023 (the “2023 10-K”).
Leases	The Company’s lease arrangements generally include real estate (manufacturing facilities, sales offices, distribution centers, warehouses), vehicles, and equipment. Leases with a term greater than one year are recognized on the Consolidated Balance Sheet; the Company has elected not to recognize leases with terms of one year or less on the Consolidated Balance Sheet. Lease obligations and their corresponding ROU assets are recorded based on the present value of lease payments over the expected lease term. The Company recognizes lease expense on a straight-line basis over the lease term. The Company's leases have lease terms ranging from 1 to 23 years, some of which include options to extend or terminate the lease. The exercise of lease renew all options is at the Company’s sole discretion. When deemed reasonably certain of exercise, the renewal options are included in the determination of the lease term. The Company’s lease agreements do not contain material residual value guarantees or any material restrictive covenants.
Effects of New Accounting Pronouncements	Effects of New Accounting Pronouncements Topics recently adopted In December 2022, the FASB issued ASU 2022-06, "Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848" from December 31, 2022 to December 31, 2024, which is superseding the date from ASU No. 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." This ASU is elective and is relief to all entities, subject to meeting certain criteria, that have contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. Optional expedients are provided for contract modification accounting under topics such as debt, leases, and derivatives. The optional amendments are effective for all entities as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through December 31, 2024. The Company modified its interest rate swap contracts during the quarter to transition from LIBOR to SOFR. The adoption of this update did not have a material impact on the Company’s consolidated financial statements. In October 2021, the FASB issued ASU No. 2021-08, "Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers." The ASU amends ASC 805 to require acquiring entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination and is intended to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity in practice and inconsistency. The ASU is effective for fiscal years beginning after December 15, 2022, including interim periods within those years, with early adoption permitted. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments. The Company adopted this standard effective April 1, 2023 and applied it in the purchase accounting for montratec. The adoption did not have a material impact on the Company's consolidated financial statements. Topics Not Yet Adopted We consider the applicability and impact of all ASUs. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The ASU is intended to provide increased transparency about income tax information through improvements to income tax disclosures related to the rate reconciliation and income taxes paid. The Company is currently assessing the impact this ASU will have on the footnotes of its annual financial statements. The Company plans to adopt this standard in fiscal 2026 when required. ASUs not listed were assessed and determined to be either not applicable, or had or are expected to have an immaterial impact on our financial statements and related disclosures.

Acquisitions & Disposals (Tables)

9 Months Ended

Dec. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Schedule of Purchase Consideration to the Assets Acquired and Liabilities

The preliminary assignment of purchase consideration to the assets acquired and liabilities assumed is as follows (in thousands):


Cash	$	7,576
Working capital	4,896
Property, plant, and equipment, net	2,157
Intangible assets	52,581
Contingent liability (see above)	(18,355)
Other assets	5,704
Other non current liabilities	(17,781)
Goodwill	78,943
Total	$	115,721

Revenue & Receivables (Tables)

9 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Balance and Related Activity for Customer Advances

The following table illustrates the balance and related activity for customer advances in the nine months ended December 31, 2023 and December 31, 2022 (in thousands):


Customer advances (contract liabilities)	December 31, 2023		December 31, 2022
March 31, beginning balance	$	27,003	$	22,453
Additional customer advances received	69,188		56,902
Revenue recognized from customer advances included in beginning of period	(27,003)		(22,453)
Other revenue recognized from customer advances	(47,055)		(34,302)
Customer advances recorded from acquisitions	3,866		—
Other (1)	284		(418)
December 31, ending balance	$	26,283	$	22,182

(1) Other includes the impact of foreign currency translation

Schedule of Disaggregation of Revenue

The following table illustrates the disaggregation of revenue by product grouping for the three and nine months ended December 31, 2023 and December 31, 2022 (in thousands):


	Three Months Ended				Nine Months Ended
Net Sales by Product Grouping	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
Industrial Products	$	83,033	$	77,423	$	253,925	$	240,366
Crane Solutions	103,775		97,541		303,746		266,959
Engineered Products	22,710		21,535		70,895		61,309
Precision Conveyor Products	44,588		33,837		119,379		113,646
All other	37		34		91		117
Total	$	254,143	$	230,370	$	748,036	$	682,397

Schedule of Balance and Related Activity for Allowance for Doubtful Accounts


Allowance for doubtful accounts	December 31, 2023		December 31, 2022
March 31, beginning balance	$	3,620	$	5,717
Bad debt expense	2,727		726
Less uncollectible accounts written off, net of recoveries	(2,490)		(996)
Allowance recorded from acquisitions	64		—
Other (1)	34		(134)
December 31, ending balance	$	3,955	$	5,313

(1) Other includes the impact of foreign currency translation

Fair Value Measurements (Tables)

9 Months Ended

Dec. 31, 2023

Fair Value Disclosures [Abstract]

Schedule of Financial Assets and Liabilities Measured or Disclosed at Fair Value

The following table provides information regarding financial assets and liabilities measured or disclosed at fair value (in thousands):


	Fair value measurements at reporting date using
	December 31,		Quoted prices in active markets for identical assets		Significant other observable inputs		Significant unobservable inputs
Description	2023		(Level 1)		(Level 2)		(Level 3)
Assets/(Liabilities) measured at fair value:
Marketable securities	$	12,388	$	12,388	$	—	$	—
Annuity contract	1,409		—		1,409		—

Derivative Assets (Liabilities):
Foreign exchange contracts	(100)		—		(100)		—
Interest rate swap	6,198		—		6,198		—
Cross currency swap	(4,506)		—		(4,506)		—


Disclosed at fair value:
Term Loan B	$	(500,048)	$	—	$	(500,048)	$	—
AR securitization facility	$	(45,000)	$	—	$	(45,000)	$	—


	Fair value measurements at reporting date using
	March 31,		Quoted prices in active markets for identical assets		Significant other observable inputs		Significant unobservable inputs
Description	2023		(Level 1)		(Level 2)		(Level 3)
Assets/(Liabilities) measured at fair value:
Marketable securities	$	10,368	$	10,368	$	—	$	—
Annuity contract	1,612		—		1,612		—
Derivative assets (liabilities):
Foreign exchange contracts	97		—		97		—

Interest rate swap	10,475		—		10,475		—
Cross currency swap	(2,102)		—		(2,102)		—

Disclosed at fair value:
Term loan B	$	(460,825)	$	—	$	(460,825)	$	—

Inventories (Tables)

9 Months Ended

Dec. 31, 2023

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories consisted of the following (in thousands):


	December 31, 2023		March 31, 2023
At cost - FIFO basis:
Raw materials	$	167,833	$	142,490
Work-in-process	26,788		26,323
Finished goods	41,449		39,714
Total at cost FIFO basis	236,070		208,527
LIFO cost less than FIFO cost	(31,674)		(29,168)
Net inventories	$	204,396	$	179,359

Goodwill and Intangible Assets (Tables)

9 Months Ended

Dec. 31, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Goodwill

A summary of changes in goodwill during the nine months ended December 31, 2023 is as follows (in thousands):


Balance at April 1, 2023	$	644,629
Acquisition of montratec (Refer to Note 2)	78,943
Currency translation	4,855
Balance at December 31, 2023	728,427

Schedule of Identifiable Intangible Assets

Identifiable intangible assets are summarized as follows (in thousands):


	December 31, 2023						March 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Trademark	$	22,576	$	(7,582)	$	14,994	$	19,478	$	(6,315)	$	13,163
Indefinite lived trademark	46,672		—		46,672		46,338		—		46,338
Customer relationships	359,264		(104,850)		254,414		322,658		(88,685)		233,973
Acquired technology	112,894		(33,342)		79,552		96,291		(27,945)		68,346
Other	3,801		(3,116)		685		3,585		(2,868)		717
Total	$	545,207	$	(148,890)	$	396,317	$	488,350	$	(125,813)	$	362,537

Schedule of Finite-Lived Intangible Assets

Identifiable intangible assets are summarized as follows (in thousands):


	December 31, 2023						March 31, 2023
	Gross Carrying Amount		Accumulated Amortization		Net		Gross Carrying Amount		Accumulated Amortization		Net
Trademark	$	22,576	$	(7,582)	$	14,994	$	19,478	$	(6,315)	$	13,163
Indefinite lived trademark	46,672		—		46,672		46,338		—		46,338
Customer relationships	359,264		(104,850)		254,414		322,658		(88,685)		233,973
Acquired technology	112,894		(33,342)		79,552		96,291		(27,945)		68,346
Other	3,801		(3,116)		685		3,585		(2,868)		717
Total	$	545,207	$	(148,890)	$	396,317	$	488,350	$	(125,813)	$	362,537

Derivative Instruments (Tables)

9 Months Ended

Dec. 31, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Derivative Instruments Effect on Condensed Consolidated Statements of Operations

The following is the effect of derivative instruments on the Condensed Consolidated Statements of Operations for the three months ended December 31, 2023 and 2022 (in thousands):

Derivatives Designated as Cash Flow Hedges

Type of Instrument

Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives

Location of Gain or (Loss) Recognized in Income on Derivatives

Amount of Gain or (Loss) Reclassified from AOCL into Income

December 31, 2023

Foreign exchange contracts

(31)

Cost of products sold

(22)

December 31, 2023

Interest rate swaps

(1,958)

Interest expense

2,566

December 31, 2023

Cross currency swaps

(2,921)

Foreign currency exchange (gain) loss

(3,248)

December 31, 2022

Foreign exchange contracts

137

Cost of products sold

(64)

December 31, 2022

Interest rate swap

1,018

Interest expense

1,170

December 31, 2022

Cross currency swaps

(6,004)

Foreign currency exchange (gain) loss

(7,916)

The following is the effect of derivative instruments on the Condensed Consolidated Statements of Operations for the nine months ended December 31, 2023 and 2022 (in thousands):

Derivatives Designated as Cash Flow Hedges

Type of Instrument

Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives

Location of Gain or (Loss) Recognized in Income on Derivatives

Amount of Gain or (Loss) Reclassified from AOCL into Income

December 31, 2023

Foreign exchange contracts

(211)

Cost of products sold

(75)

December 31, 2023

Interest rate swaps

4,131

Interest expense

7,424

December 31, 2023

Cross currency swaps

(1,701)

Foreign currency exchange (gain) loss

(1,200)

December 31, 2022

Foreign exchange contracts

Cost of products sold

(153)

December 31, 2022

Interest rate swap

7,423

Interest expense

488

December 31, 2022

Cross currency swaps

5,623

Foreign currency exchange (gain) loss

3,464

Schedule of Derivative Instruments

The following is information relative to the Company’s derivative instruments in the Condensed Consolidated Balance Sheets (in thousands):


		Fair Value of Asset (Liability)
Derivatives Designated as Hedging Instruments	Balance Sheet Location	December 31, 2023		March 31, 2023
Foreign exchange contracts	Prepaid expenses and other	$	22	$	—
Foreign exchange contracts	Other Asset	—		136
Foreign exchange contracts	Accrued liabilities	(122)		(39)
Interest rate swap	Prepaid expenses and other	7,501		7,644
Interest rate swap	Other assets	433		3,218
Interest rate swap	Accrued liabilities	—		(387)
Interest rate swap	Other non current liabilities	(1,736)		—
Cross currency swap	Prepaid expenses and other	—		168
Cross currency swap	Accrued liabilities	(284)		—
Cross currency swap	Other non current liabilities	(4,222)		(2,270)

Net Periodic Benefit Cost (Tables)

9 Months Ended

Dec. 31, 2023

Retirement Benefits [Abstract]

Schedule of Components of Net Periodic Pension Cost

The following table sets forth the components of net periodic pension cost for the Company’s defined benefit pension plans (in thousands):


	Three Months Ended				Nine Months Ended
	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
Service costs	$	136	$	199	$	389	$	536
Interest cost	3,419		2,848		10,351		8,537
Expected return on plan assets	(2,867)		(2,709)		(8,759)		(8,130)
Net amortization	62		192		266		607
Settlement	$	4,639	$	—	$	4,720	$	—
Net periodic pension (benefit) cost	$	5,389	$	530	$	6,967	$	1,550

Earnings Per Share (Tables)

9 Months Ended

Dec. 31, 2023

Earnings Per Share [Abstract]

Schedule of Computation of Basic and Diluted Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (in thousands):


	Three Months Ended				Nine Months Ended
	December 31, 2023		December 31, 2022		December 31, 2023		December 31, 2022
Numerator for basic and diluted earnings per share:
Net income (loss)	$	9,728	$	12,029	$	34,816	$	34,534

Denominators:
Weighted-average common stock outstanding – denominator for basic EPS	28,744		28,626		28,711		28,597
Effect of dilutive employee stock options and other share-based awards	247		152		268		170
Adjusted weighted-average common stock outstanding and assumed conversions – denominator for diluted EPS	28,991		28,778		28,979		28,767

Loss Contingencies (Tables)

9 Months Ended

Dec. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Reconciliation for Accrued General and Product Liability

The following table provides a reconciliation of the beginning and ending balances for accrued general and product liability (in thousands):


	December 31, 2023		March 31, 2023
Accrued general and product liability, beginning of period	$	21,103	$	22,575
Estimated insurance recoveries	(773)		(889)
Add provision for claims	1,251		3,025
Deduct payments for claims	(2,231)		(3,608)
Accrued general and product liability, end of period	$	19,350	$	21,103

Estimated insurance recoveries	(7,496)		(8,272)
Net accrued general and product liability, end of period	$	11,854	$	12,831

Changes in Accumulated Other Comprehensive Loss (Tables)

9 Months Ended

Dec. 31, 2023

Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]

Schedule of Changes in AOCL by Component

Changes in AOCL by component for the three and nine months ended December 31, 2023 are as follows (in thousands):


	Three months ended December 31, 2023
	Retirement Obligations		Foreign Currency		Change in Derivatives Qualifying as Hedges		Total
Beginning balance net of tax	$	(12,966)	$	(39,134)	$	7,385	$	(44,715)
Other comprehensive income (loss) before reclassification	1,094		13,339		(4,910)		9,523
Amounts reclassified from other comprehensive loss	3,501		—		704		4,205
Net current period other comprehensive income (loss)	4,595		13,339		(4,206)		13,728
Ending balance net of tax	$	(8,371)	$	(25,795)	$	3,179	$	(30,987)


	Nine Months Ended December 31, 2023
	Retirement Obligations		Foreign Currency		Change in Derivatives Qualifying as Hedges		Total
Beginning balance net of tax	$	(12,800)	$	(32,352)	$	7,109	$	(38,043)
Other comprehensive income (loss) before reclassification	773		6,557		2,219		9,549
Amounts reclassified from other comprehensive loss	3,656		—		(6,149)		(2,493)
Net current period other comprehensive income (loss)	4,429		6,557		(3,930)		7,056
Ending balance net of tax	$	(8,371)	$	(25,795)	$	3,179	$	(30,987)

Schedule of Amounts Reclassified Out of AOCL

Details of amounts reclassified out of AOCL for the three months ended December 31, 2023 are as follows (in thousands):


Details of AOCL Components	Amount reclassified from AOCL		Affected line item on Condensed Consolidated Statement of Operations






Net amortization of prior service cost and pension settlement expense
	$	4,652
	4,652		Total before tax
	(1,151)		Tax (benefit) expense
	$	3,501	Net of tax

Change in derivatives qualifying as hedges
	$	29	Cost of products sold
	(3,389)		Interest expense
	4,290		Foreign currency
	930		Total before tax
	(226)		Tax (benefit) expense
	$	704	Net of tax

Details of amounts reclassified out of AOCL for the nine months ended December 31, 2023 are as follows (in thousands):


Details of AOCL Components	Amount reclassified from AOCL		Affected line item on Condensed Consolidated Statement of Operations






Net amortization of prior service cost and pension settlement expense
	$	4,840
	4,840		Total before tax
	(1,184)		Tax (benefit) expense
	$	3,656	Net of tax

Change in derivatives qualifying as hedges
	$	99	Cost of products sold
	(9,807)		Interest expense
	1,585		Foreign currency
	(8,123)		Total before tax
	1,974		Tax (benefit) expense
	$	(6,149)	Net of tax

Leases (Tables)

9 Months Ended

Dec. 31, 2023

Leases [Abstract]

Schedule of Lease-Related Assets and Liabilities

The following table illustrates the lease-related assets and liabilities recorded on the Condensed Consolidated Balance Sheet (in thousands):


	December 31, 2023		March 31, 2023
Operating leases:
Other assets	$	65,424	$	53,551

Accrued liabilities	9,511		7,966
Other non current liabilities	58,763		46,524
Total operating liabilities	$	68,274	$	54,490

Finance lease:
Net property, plant, and equipment	$	11,846	$	12,597

Current portion of long-term debt and finance lease obligation	652		604
Term loan and finance lease obligations	12,441		12,937
Total finance liabilities	$	13,093	$	13,541

Schedule of Supplemental Cash Flow Information Related to Leases

Supplemental cash flow information related to leases is as follows (in thousands):


	Nine Months Ended December 31,
	2023		2022
Cash paid for amounts included in the measurement of operating lease liabilities	$	7,771	$	6,678
Cash paid for amounts included in the measurement of finance lease liabilities	$	898	$	872
ROU assets obtained in exchange for new operating lease liabilities	$	17,442	$	8,592

Description of Business (Details)	9 Months Ended
Description of Business (Details)	Dec. 31, 2023
UNITED STATES \| Revenue from Contract with Customer Benchmark \| Geographic Concentration Risk
Concentration Risk [Line Items]
Concentration risk, percentage	56.00%

Acquisitions & Disposals - Narrative (Details) - USD ($) $ in Thousands		1 Months Ended	3 Months Ended	6 Months Ended	7 Months Ended	9 Months Ended
	May 31, 2023	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2023	Dec. 31, 2023	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2023
Business Acquisition [Line Items]
Payments to acquire businesses, net of cash acquired						$ 108,145	$ 1,616
Debt instrument increase in face amount	$ 75,000					75,000
Goodwill			$ 728,427	$ 728,427	$ 728,427	728,427		$ 644,629
New Revolving Credit Facility
Business Acquisition [Line Items]
Proceeds from (repayments of) debt	117,000				120,000
Secured Debt \| AR securitization facility
Business Acquisition [Line Items]
Long-term debt	45,000		45,000	45,000	45,000	45,000
Montratec
Business Acquisition [Line Items]
Payments to acquire businesses, net of cash acquired	115,721
Cash acquired from acquisition	7,576
Payments for (proceeds from) previous acquisition	540	$ 540
Contingent liability	18,355		18,355	18,355	$ 18,355	18,355
Decrease in contingent liability				$ 6,738
Acquisition costs, period cost			$ 113			$ 3,208
Goodwill	$ 78,943
Goodwill, purchase accounting adjustments		6,414
Deferred taxes, business combination, valuation allowance, available to reduce goodwill		577
Business combination, provisional information, initial accounting incomplete, adjustment, property, plant, and equipment		209
Weighted-average amortization periods	14 years
Business acquisition, goodwill, expected tax deductible amount	$ 7,531
Montratec \| Customer relationships
Business Acquisition [Line Items]
Indefinite-lived intangible assets acquired		33,471
Montratec \| Trademark
Business Acquisition [Line Items]
Finite-lived intangible assets acquired		2,915
Montratec \| Patents
Business Acquisition [Line Items]
Finite-lived intangible assets acquired		16,196
Montratec \| Right of Use Asset
Business Acquisition [Line Items]
Business combination, provisional information, initial accounting incomplete, adjustments related to previous period		108
Montratec \| Working Capital
Business Acquisition [Line Items]
Business combination, provisional information, initial accounting incomplete, adjustments related to previous period		$ 260

Acquisitions & Disposals - Schedule of Purchase Consideration to the Assets Acquired and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	May 31, 2023	Mar. 31, 2023
Business Acquisition [Line Items]
Goodwill	$ 728,427		$ 644,629
Montratec
Business Acquisition [Line Items]
Cash		$ 7,576
Working capital		4,896
Property, plant, and equipment, net		2,157
Intangible assets		52,581
Contingent liability (see above)	$ (18,355)	(18,355)
Other assets		5,704
Other non current liabilities		(17,781)
Goodwill		78,943
Total		$ 115,721

Revenue & Receivables - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2023	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Custom engineered products and services, standard contract duration	3 months
Custom engineered products and services, contract duration	1 year
Standard warranty period	12 months
Contract asset balance	$ 1,500	$ 2,944
Revenue remaining performance obligation amount	$ 11,307
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Disaggregation of Revenue [Line Items]
Revenue remaining performance obligation percentage	52.00%
Revenue, remaining performance obligation, expected timing of satisfaction, period	12 months
Minimum
Disaggregation of Revenue [Line Items]
Standard product contract terms	30 days
Standard custom warranty period	24 months
Maximum
Disaggregation of Revenue [Line Items]
Standard product contract terms	60 days
Standard custom warranty period	36 months

Revenue & Receivables - Schedule of Balance and Related Activity for Customer Advances (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
March 31, beginning balance	$ 27,003	$ 22,453
Additional customer advances received	69,188	56,902
Revenue recognized from customer advances included in beginning of period	(27,003)	(22,453)
Other revenue recognized from customer advances	(47,055)	(34,302)
Customer advances recorded from acquisitions	3,866	0
Other	284	(418)
December 31, ending balance	$ 26,283	$ 22,182

Revenue & Receivables - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Disaggregation of Revenue [Line Items]
Net sales	$ 254,143	$ 230,370	$ 748,036	$ 682,397
Industrial Products
Disaggregation of Revenue [Line Items]
Net sales	83,033	77,423	253,925	240,366
Crane Solutions
Disaggregation of Revenue [Line Items]
Net sales	103,775	97,541	303,746	266,959
Engineered Products
Disaggregation of Revenue [Line Items]
Net sales	22,710	21,535	70,895	61,309
Precision Conveyor Products
Disaggregation of Revenue [Line Items]
Net sales	44,588	33,837	119,379	113,646
All other
Disaggregation of Revenue [Line Items]
Net sales	$ 37	$ 34	$ 91	$ 117

Revenue & Receivables - Schedule of Balance and Related Activity for Allowance for Doubtful Accounts (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
March 31, beginning balance	$ 3,620	$ 5,717
December 31, ending balance	3,955	5,313
SEC Schedule, 12-09, Allowance, Credit Loss
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Bad debt expense	2,727	726
Less uncollectible accounts written off, net of recoveries	(2,490)	(996)
Allowance recorded from acquisitions	64	0
Other	$ 34	$ (134)

Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured or Disclosed at Fair Value (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	$ 12,388	$ 10,368
Term Loan B
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, fair value	(500,048)	(460,825)
AR securitization facility
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, fair value	(45,000)
Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	(100)	97
Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	6,198	10,475
Cross currency swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	(4,506)	(2,102)
Quoted Prices in Active Markets for Indentical Assets (Level 1) \| Term Loan B
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, fair value	0	0
Quoted Prices in Active Markets for Indentical Assets (Level 1) \| AR securitization facility
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, fair value	0
Quoted Prices in Active Markets for Indentical Assets (Level 1) \| Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	0	0
Quoted Prices in Active Markets for Indentical Assets (Level 1) \| Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	0	0
Quoted Prices in Active Markets for Indentical Assets (Level 1) \| Cross currency swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	0	0
Significant Other Observable Inputs (Level 2) \| Term Loan B
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, fair value	(500,048)	(460,825)
Significant Other Observable Inputs (Level 2) \| AR securitization facility
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, fair value	(45,000)
Significant Other Observable Inputs (Level 2) \| Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	(100)	97
Significant Other Observable Inputs (Level 2) \| Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	6,198	10,475
Significant Other Observable Inputs (Level 2) \| Cross currency swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	(4,506)	(2,102)
Significant unobservable Inputs (Level 3) \| Term Loan B
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, fair value	0	0
Significant unobservable Inputs (Level 3) \| AR securitization facility
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, fair value	0
Significant unobservable Inputs (Level 3) \| Foreign exchange contracts
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	0	0
Significant unobservable Inputs (Level 3) \| Interest rate swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative assets	0	0
Significant unobservable Inputs (Level 3) \| Cross currency swaps
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative liability	0	0
Marketable securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	12,388	10,368
Marketable securities \| Quoted Prices in Active Markets for Indentical Assets (Level 1)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	12,388	10,368
Marketable securities \| Significant Other Observable Inputs (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	0	0
Marketable securities \| Significant unobservable Inputs (Level 3)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Marketable securities	0	0
Annuity contract
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Annuity contract	1,409	1,612
Annuity contract \| Quoted Prices in Active Markets for Indentical Assets (Level 1)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Annuity contract	0	0
Annuity contract \| Significant Other Observable Inputs (Level 2)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Annuity contract	1,409	1,612
Annuity contract \| Significant unobservable Inputs (Level 3)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Annuity contract	$ 0	$ 0

Fair Value Measurements - Narrative (Details) $ in Millions	Dec. 31, 2023 USD ($)	May 31, 2023 USD ($)
Royalty and asset volatility rate \| Contingent liability
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Significant valuation inputs	0.27
Weighted average cost of capital
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Significant valuation inputs	0.125
Customer relationships \| Attrition rate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Significant valuation inputs	0.100
Acquired technology \| Royalty and asset volatility rate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Significant valuation inputs	0.050
Trademarks and trade names \| Royalty and asset volatility rate
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Significant valuation inputs	0.010
Secured Debt \| AR securitization facility
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt	$ 45	$ 45

Inventories - Schedule of Inventories (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 167,833	$ 142,490
Work-in-process	26,788	26,323
Finished goods	41,449	39,714
Total at cost FIFO basis	236,070	208,527
LIFO cost less than FIFO cost	(31,674)	(29,168)
Net inventories	$ 204,396	$ 179,359

Inventories - Narrative (Details) - USD ($) $ in Thousands	9 Months Ended
Inventories - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Inventory [Line Items]
Increase in inventories	$ 17,764	$ 31,701
Montratec
Inventory [Line Items]
Increase in inventories	$ 4,083

Marketable Securities and Other Investments (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2023
Gain (Loss) on Securities [Line Items]
Unrealized gain (loss) on investments	$ 660	$ 362	$ 390	$ (558)
Dividend received from equity method investment			144	$ 313
Accounts receivable balance	173,411		173,411		$ 151,451
Related Party \| EMC
Gain (Loss) on Securities [Line Items]
Accounts receivable balance	$ 8,105		$ 8,105		5,083
EMC
Gain (Loss) on Securities [Line Items]
Ownership interest	49.00%	49.00%	49.00%	49.00%
Carrying values of investments	$ 3,132		$ 3,132		$ 2,752
Investment income	$ 5	$ 142	589	$ 209
Dividend received from equity method investment			$ 247	$ 313

Goodwill and Intangible Assets - Narrative (Details) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2023 USD ($) reportingUnit	Dec. 31, 2022 USD ($)	Mar. 31, 2023 USD ($) reportingUnit
Goodwill [Line Items]
Number of reporting units \| reportingUnit			3		3
Goodwill	$ 728,427		$ 728,427		$ 644,629
Goodwill accumulated impairment loss	$ 113,174		$ 113,174		113,174
Finite-lived intangible asset, useful life	16 years		16 years
Indefinite-lived trademarks	$ 46,672		$ 46,672		46,338
Amortization of Intangible Assets	7,486	$ 6,459	21,871	$ 19,442
Estimated annual amortization expense next year	30,000		30,000
Estimated annual amortization expense two years from current year	30,000		30,000
Estimated annual amortization expense three years from current year	30,000		30,000
Estimated annual amortization expense four years from current year	30,000		30,000
Estimated annual amortization expense five years from current year	$ 30,000		$ 30,000
Trademark
Goodwill [Line Items]
Finite-lived intangible asset, useful life	13 years		13 years
Customer relationships
Goodwill [Line Items]
Finite-lived intangible asset, useful life	17 years		17 years
Acquired technology
Goodwill [Line Items]
Finite-lived intangible asset, useful life	15 years		15 years
Other
Goodwill [Line Items]
Finite-lived intangible asset, useful life	5 years		5 years
Duff Norton Group
Goodwill [Line Items]
Goodwill	$ 9,699		$ 9,699		9,699
Rest of Products
Goodwill [Line Items]
Goodwill	308,693		308,693		306,988
Precision Conveyance
Goodwill [Line Items]
Goodwill	$ 410,035		$ 410,035		$ 327,942

Goodwill and Intangible Assets - Schedule of Goodwill (Details) $ in Thousands	9 Months Ended
	Dec. 31, 2023 USD ($)
Goodwill [Roll Forward]
Balance at April 1, 2023	$ 644,629
Acquisition of montratec (Refer to Note 2)	78,943
Currency translation	4,855
Balance at December 31, 2023	$ 728,427

Goodwill and Intangible Assets - Schedule of Identifiable Intangible Assets (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Accumulated Amortization	$ (148,890)	$ (125,813)
Indefinite lived trademark	46,672	46,338
Gross Carrying Amount	545,207	488,350
Net	396,317	362,537
Trademark
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	22,576	19,478
Accumulated Amortization	(7,582)	(6,315)
Net	14,994	13,163
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	359,264	322,658
Accumulated Amortization	(104,850)	(88,685)
Net	254,414	233,973
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	112,894	96,291
Accumulated Amortization	(33,342)	(27,945)
Net	79,552	68,346
Other
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	3,801	3,585
Accumulated Amortization	(3,116)	(2,868)
Net	$ 685	$ 717

Derivative Instruments - Narrative (Details) $ in Thousands	Dec. 31, 2023 USD ($) contract
Minimum
Derivatives, Fair Value [Line Items]
Long-term debt percentage bearing fixed interest rate	50.00%
Long-term debt percentage variable interest rate	30.00%
Maximum
Derivatives, Fair Value [Line Items]
Long-term debt percentage bearing fixed interest rate	70.00%
Long-term debt percentage variable interest rate	50.00%
Cross currency swaps \| Derivatives Designated as Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Notional amount of derivative	$ 99,378
Interest rate cash flow hedge gain (loss) to be reclassified during next 12 months, net	211
Foreign exchange contracts \| Derivatives Designated as Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Notional amount of derivative	4,591
Interest rate cash flow hedge gain (loss) to be reclassified during next 12 months, net	$ 68
Interest rate swaps
Derivatives, Fair Value [Line Items]
Derivative, number of instruments held \| contract	2
Interest rate swaps \| Derivatives Designated as Cash Flow Hedges
Derivatives, Fair Value [Line Items]
Notional amount of derivative	$ 353,224
Interest rate cash flow hedge gain (loss) to be reclassified during next 12 months, net	$ 5,638

Derivative Instruments - Schedule of Derivative Instruments Effect on Condensed Consolidated Statements of Operations (Details) - Derivatives Designated as Cash Flow Hedges - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Foreign exchange contracts
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives	$ (31)	$ 137	$ (211)	$ 89
Amount of Gain or (Loss) Reclassified from AOCL into Income	(22)	(64)	(75)	(153)
Interest rate swaps
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives	(1,958)	1,018	4,131	7,423
Amount of Gain or (Loss) Reclassified from AOCL into Income	2,566	1,170	7,424	488
Cross currency swaps
Derivative Instruments, Gain (Loss) [Line Items]
Amount of Gain or (Loss) Recognized in Other Comprehensive Income (Loss) on Derivatives	(2,921)	(6,004)	(1,701)	5,623
Amount of Gain or (Loss) Reclassified from AOCL into Income	$ (3,248)	$ (7,916)	$ (1,200)	$ 3,464

Derivative Instruments - Schedule of Derivative Instruments (Details) - Derivatives Designated as Cash Flow Hedges - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Prepaid expenses and other \| Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	$ 22	$ 0
Prepaid expenses and other \| Interest rate swaps
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	7,501	7,644
Prepaid expenses and other \| Cross currency swaps
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	0	168
Other assets \| Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	0	136
Other assets \| Interest rate swaps
Derivatives, Fair Value [Line Items]
Derivative assets, fair value	433	3,218
Accrued liabilities \| Foreign exchange contracts
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	(122)	(39)
Accrued liabilities \| Interest rate swaps
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	0	(387)
Accrued liabilities \| Cross currency swaps
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	(284)	0
Other non current liabilities \| Interest rate swaps
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	(1,736)	0
Other non current liabilities \| Cross currency swaps
Derivatives, Fair Value [Line Items]
Derivative liability, fair value	$ (4,222)	$ (2,270)

Debt (Details)		9 Months Ended
Debt (Details)	May 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Mar. 31, 2023 USD ($)
Line of Credit Facility [Line Items]
Line of credit facility increase in borrowing capacity		$ 75,000,000
Line of credit facility, maximum borrowing capacity		175,000,000
Debt instrument increase in face amount	$ 75,000,000	75,000,000
Accounts receivable balance		173,411,000	$ 151,451,000
Current portion of long-term debt and finance lease obligations		50,652,000	40,604,000
Deferred financing costs		7,845,000	6,323,000
Accumulated amortization of deferred financing costs		$ 2,663,000	1,815,000
Finance lease term		23 years
Outstanding balance on finance lease obligation		$ 13,093,000	13,541,000
Current portion of long-term debt and finance lease obligation		652,000	604,000
Unsecured Lines of Credit
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity		2,428,000
Outstanding borrowings		0
UNITED STATES
Line of Credit Facility [Line Items]
Accounts receivable balance		72,736,000
Secured Debt \| Loans
Line of Credit Facility [Line Items]
Deferred financing costs gross		2,414,000	892,000
Secured Debt \| AR securitization facility
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity		55,000,000
Long-term debt	$ 45,000,000	45,000,000
Deferred financing costs gross		536,000
Accumulated amortization of deferred financing costs		$ 104,000
Secured Debt \| AR securitization facility \| Secured Overnight Financing Rate S O F R Member
Line of Credit Facility [Line Items]
Debt instrument, credit spread adjustment on variable rate		0.0010
Debt instrument, basis spread on variable rate		1.10%
Term Loan B
Line of Credit Facility [Line Items]
Outstanding borrowings		$ 497,560,000
Repayments of long-term debt		40,000,000
Periodic payment required		4,585,000
Current portion of long-term debt and finance lease obligations		6,113,000
Planned principal payments during next 12 months		50,000,000
New Revolving Credit Facility
Line of Credit Facility [Line Items]
Outstanding letters of credit		15,740,000
Increase in deferred financing costs noncurrent		801,000
New Revolving Credit Facility \| Letter of Credit
Line of Credit Facility [Line Items]
Outstanding letters of credit		171,000
New Revolving Credit Facility \| Standby Letters of Credit
Line of Credit Facility [Line Items]
Outstanding letters of credit		15,569,000
Revolving Credit Facility
Line of Credit Facility [Line Items]
Accumulated amortization of deferred financing costs		2,385,000	1,611,000
Deferred financing costs noncurrent		4,828,000	$ 4,027,000
Bank Guarantees \| Unsecured Lines of Credit
Line of Credit Facility [Line Items]
Line of credit facility, maximum borrowing capacity		13,541,000
Outstanding borrowings		$ 10,758,000

Net Periodic Benefit Cost - Schedule of Components of Net Periodic Pension Cost (Details) - Pension Plans, Defined Benefiit - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Defined Benefit Plan Disclosure [Line Items]
Service costs	$ 136	$ 199	$ 389	$ 536
Interest cost	3,419	2,848	10,351	8,537
Expected return on plan assets	(2,867)	(2,709)	(8,759)	(8,130)
Net amortization	62	192	266	607
Settlement	4,639	0	4,720	0
Net periodic pension (benefit) cost	$ 5,389	$ 530	$ 6,967	$ 1,550

Net Periodic Benefit Cost - Narrative (Details) $ in Thousands	3 Months Ended
	Dec. 31, 2023 USD ($)
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, expected future employer contributions	$ 6,908
Pension Plans, Defined Benefiit
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, net periodic benefit cost due to settlement	$ 4,599

Earnings Per Share - Schedule of Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended						9 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Numerator for basic and diluted earnings per share:
Net income (loss)	$ 9,728	$ 15,813	$ 9,275	$ 12,029	$ 14,114	$ 8,391	$ 34,816	$ 34,534
Denominators:
Weighted-average common stock outstanding – denominator for basic EPS (in shares)	28,744			28,626			28,711	28,597
Effect of dilutive employee stock options and other share-based awards (in shares)	247			152			268	170
Adjusted weighted-average common stock outstanding and assumed conversions – denominator for diluted EPS (in shares)	28,991			28,778			28,979	28,767

Earnings Per Share - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands			1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Feb. 20, 2024	Jan. 22, 2024	Jun. 30, 2019	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Contingently issuable common shares were excluded (in shares)				165,000	179,000	165,000	179,000
Treasury stock purchase (in shares)								31,000
Treasury stock, value				$ 1,001		$ 1,001		$ 1,001
Dividends declared per common share (in dollars per share)				$ 0.07	$ 0.07	$ 0.14	$ 0.14
Subsequent Event
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividends declared per common share (in dollars per share)		$ 0.07
Subsequent Event \| Forecast
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividends	$ 2,015
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares vested (in shares)								133,000
2016 LTIP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Additional shares authorized for grant (in shares)			2,500,000
Stock issued upon the exercise of stock option (in shares)						21,000
Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)				824,000	715,000	744,000	715,000

Loss Contingencies - Narrative (Details) $ in Thousands, € in Millions	1 Months Ended							2 Months Ended	3 Months Ended	9 Months Ended
	Sep. 30, 2017 company	Feb. 28, 2017 memorandum	Dec. 31, 2016 judgement appeal	Aug. 31, 2012 USD ($) notice	Aug. 31, 2012 EUR (€) notice	Nov. 30, 2010 USD ($)	Nov. 30, 2010 EUR (€)	May 31, 2023 decision	Sep. 30, 2020 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)
Product Liability Contingency [Line Items]
Loss contingency accrual											$ 19,350	$ 21,103	$ 22,575
Estimated insurance recoveries											(7,496)	$ (8,272)
Per occurrence limits on self insurance for general and product liability coverage through FY 2003											2,000
Per occurrence limits on self insurance for general and product liability coverage from FY 2004 through current FY											3,000
General and product liability insurance limit											75,000
Estimation of asbestos-related aggregate liability that is probable and estimable											$ 6,414
Loss contingency period											38 years
Gross defense costs prior to retro premiums required by settlement, percentage									0.65
Indemnity costs covered by insurance, percentage											1
Net accrued general and product liability, end of period											$ 4,664
Amount of alleged taxes owed				$ 7,400	€ 6.7	$ 2,100	€ 1.9
Amount of alleged taxes owed including penalties and interest				$ 3,100	€ 2.8	$ 2,400	€ 2.2
Number of tax assessment notices, issued \| notice				4	4
Number of appeals in Italian supreme court \| appeal			2
Number of positive judgments on tax assessments \| judgement			2
Number of filed memorandum before the italian supreme court \| memorandum		2
Number of decisions \| decision								2
Number of companies as co-defendants \| company	5
Accrual for environmental loss contingencies											727
Magnetek
Product Liability Contingency [Line Items]
Loss contingency accrual											776
DEP
Product Liability Contingency [Line Items]
Accrual for environmental loss contingencies											314
Forecast
Product Liability Contingency [Line Items]
Asbestos liability payments										$ 2,700
Loss settlement gross period										12 months
Minimum
Product Liability Contingency [Line Items]
Product liability coverage limit											2,000
Estimation of asbestos-related aggregate liability that is probable and estimable											4,900
Maximum
Product Liability Contingency [Line Items]
Product liability coverage limit											6,000
Estimation of asbestos-related aggregate liability that is probable and estimable											8,900
Litigation settlement claim payable									$ 1,650
Other non current liabilities
Product Liability Contingency [Line Items]
Loss contingency accrual, product liability											14,750
Accrued liabilities
Product Liability Contingency [Line Items]
Loss contingency accrual, product liability											$ 4,600

Loss Contingencies - Schedule of Reconciliation for Accrued General and Product Liability (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Dec. 31, 2023	Mar. 31, 2023
Loss Contingency Accrual [Roll Forward]
Accrued general and product liability, beginning of period	$ 21,103	$ 22,575
Estimated insurance recoveries	(773)	(889)
Add provision for claims	1,251	3,025
Deduct payments for claims	(2,231)	(3,608)
Accrued general and product liability, end of period	19,350	21,103
Estimated insurance recoveries	(7,496)	(8,272)
Net accrued general and product liability, end of period	$ 11,854	$ 12,831

Income Taxes (Details)	3 Months Ended		9 Months Ended		12 Months Ended
Income Taxes (Details)	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022	Mar. 31, 2024
Income Tax Contingency [Line Items]
Effective income tax rate	29.00%	28.00%	26.00%	35.00%
Effective income tax rate reconciliation tax settlement percent				5.00%
Effective income tax rate reconciliation change in deferred tax assets valuation allowance percent				4.00%
Minimum \| Forecast
Income Tax Contingency [Line Items]
Effective income tax rate					24.00%
Maximum \| Forecast
Income Tax Contingency [Line Items]
Effective income tax rate					26.00%

Changes in Accumulated Other Comprehensive Loss - Schedule of Changes in AOCL by Component (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	$ 853,998	$ 784,384	$ 833,797	$ 772,803
Other comprehensive income (loss) before reclassification	9,523		9,549
Amounts reclassified from other comprehensive loss	4,205		(2,493)
Total other comprehensive income (loss)	13,728	14,004	7,056	2,209
Ending balance	878,437	810,881	878,437	810,881
Accumulated Other Comprehensive Loss
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(44,715)	(61,694)	(38,043)	(49,899)
Ending balance	(30,987)	$ (47,690)	(30,987)	$ (47,690)
Retirement Obligations
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(12,966)		(12,800)
Other comprehensive income (loss) before reclassification	1,094		773
Amounts reclassified from other comprehensive loss	3,501		3,656
Total other comprehensive income (loss)	4,595		4,429
Ending balance	(8,371)		(8,371)
Foreign Currency
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	(39,134)		(32,352)
Other comprehensive income (loss) before reclassification	13,339		6,557
Amounts reclassified from other comprehensive loss	0		0
Total other comprehensive income (loss)	13,339		6,557
Ending balance	(25,795)		(25,795)
Change in Derivatives Qualifying as Hedges
AOCI Attributable to Parent, Net of Tax [Roll Forward]
Beginning balance	7,385		7,109
Other comprehensive income (loss) before reclassification	(4,910)		2,219
Amounts reclassified from other comprehensive loss	704		(6,149)
Total other comprehensive income (loss)	(4,206)		(3,930)
Ending balance	$ 3,179		$ 3,179

Changes in Accumulated Other Comprehensive Loss - Schedule of Amounts Reclassified Out of AOCL (Details) - USD ($) $ in Thousands	3 Months Ended						9 Months Ended
	Dec. 31, 2023	Sep. 30, 2023	Jun. 30, 2023	Dec. 31, 2022	Sep. 30, 2022	Jun. 30, 2022	Dec. 31, 2023	Dec. 31, 2022
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other nonoperating income (expense)	$ (5,234)			$ (79)			$ (5,840)	$ 1,999
Cost of products sold	160,246			148,326			467,513	431,516
Interest expense	9,952			7,303			28,788	20,274
Foreign currency	1,155			3,359			(1,074)	1,152
Income (loss) before income tax expense (benefit)	13,639			16,730			47,221	53,081
Tax (benefit) expense	(3,911)			(4,701)			(12,405)	(18,547)
Net income (loss)	9,728	$ 15,813	$ 9,275	$ 12,029	$ 14,114	$ 8,391	34,816	$ 34,534
Net amortization of prior service cost and pension settlement expense \| Amount reclassified from AOCL
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Other nonoperating income (expense)	4,652						4,840
Income (loss) before income tax expense (benefit)	4,652						4,840
Tax (benefit) expense	(1,151)						(1,184)
Net income (loss)	3,501						3,656
Change in derivatives qualifying as hedges \| Amount reclassified from AOCL
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Cost of products sold	29						99
Interest expense	(3,389)						(9,807)
Foreign currency	4,290						1,585
Income (loss) before income tax expense (benefit)	930						(8,123)
Tax (benefit) expense	(226)						1,974
Net income (loss)	$ 704						$ (6,149)

Leases - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Leases - Narrative (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Lessee, Lease, Description [Line Items]
Finance lease term	23 years		23 years
Operating lease expense	$ 3,216	$ 2,323	$ 9,429	$ 6,810
Finance lease, right-of-use asset, amortization	250	751	250	751
Finance lease, interest expense	$ 149	$ 156	$ 451	$ 470
Minimum
Lessee, Lease, Description [Line Items]
Operating lease term	1 year		1 year
Finance lease term	1 year		1 year
Maximum
Lessee, Lease, Description [Line Items]
Operating lease term	23 years		23 years
Finance lease term	23 years		23 years

Leases - Schedule of Lease-related Assets and Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Mar. 31, 2023
Operating leases:
Other assets	$ 65,424	$ 53,551
Accrued liabilities	9,511	7,966
Other non current liabilities	58,763	46,524
Total operating liabilities	68,274	54,490
Finance lease:
Net property, plant, and equipment	11,846	12,597
Current portion of long-term debt and finance lease obligation	652	604
Term loan and finance lease obligations	12,441	12,937
Total finance liabilities	$ 13,093	$ 13,541
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other assets	Other assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current	Accrued Liabilities, Current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Liabilities, Noncurrent	Other Liabilities, Noncurrent
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Current portion of long-term debt and finance lease obligations	Current portion of long-term debt and finance lease obligations
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Term loan, AR securitization facility and finance lease obligations	Term loan, AR securitization facility and finance lease obligations

Leases - Schedule of Supplemental Cash Flow Information Related to Leases (Details) - USD ($) $ in Thousands	9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Leases [Abstract]
Cash paid for amounts included in the measurement of operating lease liabilities	$ 7,771	$ 6,678
Cash paid for amounts included in the measurement of finance lease liabilities	898	872
ROU assets obtained in exchange for new operating lease liabilities	$ 17,442	$ 8,592